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Abstract
Campylobacter jejuni, a leading cause of bacterial gastroenteritis worldwide, is strongly
associated with the consumption and/or mishandling of raw contaminated poultry products. Thus,
interventions aiming to reduce C. jejuni counts on poultry products could greatly reduce the
incidence of human campylobacteriosis. In the first study, the efficacy of a generally recongnized
as safe (GRAS) compound, carvacrol (CR; derived from oregano oil), as an antimicrobial wash
treatment to reduce C. jejuni on chicken skin was evaluated. Three delivery systems of CR:
suspension, emulsion and nanoemulsion were used. C. jejuni counts were reduced up to 4 log10
cfu/sample by 2% dose of CR suspension at 0 h (P < 0.05). Carvacrol emulsion or nanoemulsion
did not show any additional reduction in C. jejuni counts when compared to suspension.
In the second study, the efficacy of gum arabic (GA) or chitosan (CH) coatings fortified
with CR to reduce C. jejuni on chicken wingettes was investigated as an additional intervention to
increase the antimicrobial activity of CR. Inoculated chicken wingettes (~7.5 log10 cfu of C.
jejuni/sample) were randomly assigned to baseline, control (0%), CR (0.25, 0.5 or 1%), GA (10%),
CH (2%) or their combinations. After 1 min of coating, wingettes were air dried (1 h) and sampled
at days 0, 1, 3, 5, and 7. All three doses of CR, CH or GA-based coating fortified with CR reduced
C. jejuni from day 0 through 7 by up to 3.0 log10 cfu/sample (P < 0.05). Moreover, the antimicrobial
efficacy of GA was improved by CR and the coatings reduced C. jejuni by ~1 to 2 log10 cfu/sample
at day 7. In addition, CH-CR coatings reduced total aerobic counts on majority of storage time
when compared with baseline. No significant difference in the color of chicken wingettes was
observed between treatments. Exposure of this pathogen to sublethal concentrations of CR, CH or
combination significantly modulated select genes encoding for energy taxis, motility, binding and

attachment. The results suggest that GA or CH-based coating with CR could potentially be used
as a natural antimicrobial to control C. jejuni in post-harvest poultry products.
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Chapter 1
Introduction

1

The implications due to foodborne illness are enormous, comprising serious public health
concern as well as significant economic and social burden. The Centers for Disease Control and
Prevention (2011) estimated that foodborne diseases account for ~48 million illnesses, 128,000
hospitalizations, and 3000 deaths each year in the United States. Among the different foodborne
bacterial pathogens, Campylobacter is one of the leading causes of foodborne illnesses, with an
estimated 1.3 million illnesses each year in the United States (CDC, 2018). This bacterium is a
commensal in the intestinal tract of poultry with the ability to colonize at high numbers in the ceca
(Beery et al., 1988), which can contaminate poultry carcasses and raw retail poultry products
during processing (Berrang et al., 2001; Miwa et al., 2003). Thus, Campylobacter infection in
humans is highly associated with consumption/or mishandling of contaminated undercooked
poultry products. With increasing consumption of poultry products globally, contaminated poultry
products pose a significant threat to public health (Coker et al., 2002; National Chicken Council,
2018). Simulations designed to predict the effect of different mitigation strategies showed that the
incidence of human campylobacteriosis associated with consumption of chicken meals could be
reduced by 30-fold by introducing a 2-log10 reduction of the number of Campylobacter on the
chicken carcasses (Rosenquist et al., 2003). Hence, reduction or elimination of this pathogen in
the poultry/poultry products is an essential step to improve poultry product safety.
With the initiation and implementation of Campylobacter monitoring and control for
poultry products by United States Department of Agriculture (USDA), it is necessary for poultry
processors to employ effective strategies to mitigate Campylobacter counts throughout processing.
In recent years, the addition of antimicrobials in post-chill decontamination tanks have provided
an innovative approach for pathogen reduction during poultry processing (McKee, 2011; Nagel et
al., 2013). Most of these antimicrobials are synthetic chemicals such as chlorine-based products,
2

peracetic acid, acidic calcium sulfate and trisodium phosphate (Sohaib et al., 2016). However,
there has been an increase in consumer demand for high quality, minimally processed and
wholesome foods with natural ingredients. In response to this changing demand, the poultry
processors have been looking for practical and natural ways to ensure safety and quality of poultry
products. In this regard, the use of natural plant-derived antimicrobials could be an effective
approach for reducing C. jejuni and thereby, improving microbial safety of raw poultry and poultry
products (Venkitanarayanan et al., 2013).
The use of carvacrol (a main component of oregano oil) as an antimicrobial wash/dip
treatment is receiving increased attention owing to the many biological properties which are
beneficial for its application in the food industry (Wagner et al., 1986; Ben Arfa et al., 2006; de
Silva Lima et al., 2013; Ouiroga et al., 2015; Jung et al., 2018). Furthermore, carvacrol is a
generally recognized as safe (GRAS) status compound (Code of Federal Regulations 21 part 172).
Previous studies from our laboratory demonstrated that carvacrol can reduce Campylobacter, both
in vitro and in vivo (Kollanoor Johny et al., 2010; Arsi et al., 2014). The potential use of carvacrol
in the food industry to improve food safety in different products has been extensively studied (Burt
et al., 2007; Juenja et al., 2008; Ravishankar et al., 2010; Nair et al., 2015). However, solubility of
carvacrol in water is a major issue, thereby, limiting its application in a commercial operation. In
addition, high concentrations of carvacrol are needed to obtain a maximum effect which could
potentially affect the meat quality and sensory properties of poultry products (Ntzimani et al.,
2011; Sánchez-González et al., 2011; Petrou et al., 2012). In this regard, recent studies have been
focusing on enhancing solubility and antimicrobial efficacy of essential oils by using novel
nanotechnology in food industry (Shrivastava et al., 2009; Kour et al., 2014; Otoni et al., 2014;
Landry et al., 2015; Gundewadi et al., 2016, 2018). The smaller size of nano-particles and larger
3

surface area are the key properties for improved solubility and antimicrobial efficacy (Jaiswal et
al., 2015).
Recent studies have highlighted the use of coating treatments to improve the shelf-life and
microbial safety on poultry products (Ricke and Hanning, 2013). Antimicrobial edible coatings or
edible coatings fortified with plant-derived antimicrobial can be used to minimize growth of
surface pathogens (Cagri et al., 2004; Upadhyay et al., 2015, Upadhyaya et al., 2016). Any type
of thin material prepared from various substances including protein, polysaccharides and lipid used
for enrobing various foods to extend the shelf-life and improve the microbial safety of the food
product that may be consumed together with that food is considered as an edible coating
(Debeaufort et al., 1998; Dehghani et al., 2018). Since antimicrobial edible coatings are not
expected to be removed before consumption, they are considered as food additives and they should
be GRAS status compounds as codified by the FDA (FDA, 2018). Gum arabic (Code of Federal
Regulations 21 part 184) is a natural gum consisting of the hardened sap of various species of the
acacia tree (Anderson et al., 1966; Islam et al., 1997). Chitosan is a linear aminopolysaccharide,
composed of β (1-4) linked D-glucosamine and N-acetly-D-glucosamine, and derived from chitin
(a structural component of crustacean shells). Both gum arabic and chitosan possess multiple
biological activities including antimicrobial activity against various pathogens (Hudson and Smith,
1998; Dutta et al., 2004; Patel and Goyal, 2015). In addition, the antimicrobial efficacy of edible
coating could be enhanced by incorporating antimicrobial essential oils such as carvacrol due to
potential synergism against C. jejuni (Elsabee and Abdou, 2013).

4

Justification
Campylobacter spp. are the most frequent cause of bacterial foodborne infections
worldwide. The human infections are often linked with either consumption or mishandling of raw
contaminated poultry products. Thus, reducing Campylobacter counts on poultry products would
greatly reduce human illnesses. To reach this goal, intervention strategies at each stage (multihurdle approach) of poultry production are warranted. As of now, there are no treatments to
eliminate Campylobacter from colonizing the gastrointestinal tract of poultry. This stresses the
importance of post-harvest interventions. Due to consumer preference for minimally processed
and no synthetic chemical treatments, the use of natural antimicrobials with GRAS status is gaining
attention for improving safety of poultry products. There is a paucity of literature on the use of
natural antimicrobials to reduce C. jejuni on poultry products. Thus, more research is needed to
find effective natural treatments to reduce/eliminate C. jejuni on poultry products.
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Chapter 2
Literature Review

11

2.1 Campylobacter
2.1.1 Historical Perspective
Campylobacter was first observed by Theodore Escherich in the stool samples from infants
with diarrhea in 1886 (Escherich, 1886), and after two decades, the organism was confirmed as
causative agent of septic abortion in cattle and sheep (McFadyean and Stockman, 1909). The type
species, Campylobacter fetus (Vibrio fetus) remained an organism primarily of veterinary concern
for many years (Altekruse et al., 1999). The first human infection was reported by Vinzet and
colleagues (1947) from the blood of three pregnant women. King (1957) was the first who studied
human strains in depth. She identified Vibrio like bacteria requiring high optimum temperature for
growth than the classical type and referred them as “related vibrios”. In 1963, Sebald and Véron
separated the microaerophilic vibrios from the genus Vibrio on the grounds that these organisms
differed from the classical cholera and halophilic groups in certain fundamental characters
(microaerophilic growth, non-fermentative metabolism and low DNA base composition) and
proposed the new genus Campylobacter (in Greek, a curved rod). Until 1972, only handful of
human cases (12) were reported in literature, the reason behind this paucity of reports was the lack
of selective media for isolating this organism (Butzler, 2004). It took a long time to realize the
endemic nature of this organism in humans due to its fastidious growth requirements and lack of
selective culturing technique (Butzler, 2004). The main hurdle for isolation of Campylobacter
from people with diarrhea was the overgrowth of other organisms present in the stool. Until 1970’s,
human infection with Campylobacter was diagnosed through microscopic observation of the
causative agents from blood samples of patients with gastroenteritis (Butzler, 2004). A door to the
isolation of Campylobacter opened by researchers Cooper and Slee (1971) when they observed
that an isolate of Campylobacter was able to grow in the presence of the antibiotic cephalothin
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when incubated in a microaerophilic atmosphere. After a year, another crucial step for the isolation
technique of Campylobacter from feces was published by Dekeyser and colleagues (1972). This
selective culture technique was based on the fact that Campylobacter is small enough to pass
through a filter (0.65 mm) that holds back other organisms. In addition, this Belgian group added
sheep blood, polymixin-B-sulfate, novobiocin, and actidoine to fluid-thioglycolate agar that made
isolation of Campylobacter from stool possible. Later, in 1977, Martin Skirrow published a
selective culture technique which was less labor intensive and more sensitive than the filtration
technique (Skirrow, 1977). The development of selective media followed by extensive research on
Campylobacter redefined the role of Campylobacter in human disease from just an opportunist to
its significantly greater role as a frequent cause of gastroenteritis (Blazer et al., 1979).
2.1.2 Microbiology
2.1.2.1 Morphology/Taxonomy
The name Campylobacter originated from the two Greek words kampylos (curved) and
baktron (rod) which briefly describes the morphology of bacterium (Sebald and Véron, 1963).
Currently, there are three closely related genera (Campylobacter, Arcobacter and Sulfurospirillum)
under family Campylobacteraceae (Lastovica et al., 2014). There are 24 species and 8 subspecies
under the genus Campylobacter (Fitzgerald and Nachamkin, 2015). However, C. jejuni
(subspecies jejuni) and C. coli are the most frequent cause of human enteritis (WHO, 2018). They
are gram negative, non-spore forming, slender, S-shaped, spirally curved rods, measuring 0.2-0.9
μm wide and 0.5-5 μm long. In addition, they have a single polar flagellum (two or three times the
length of the cells) which gives them a characteristic corkscrew kind of movement (Smibert, 1978;
Debruyne et al., 2008; Fitzgerald and Nachamkin, 2015).
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2.1.2.2 In vitro Culture Condition
The optimal growth for Campylobacter spp. is observed at 42°C under microaerophilic
conditions (5% oxygen, 10% carbon dioxide and 85% nitrogen; Park, 2002). Nevertheless, C.
jejuni displays physiological activity even at 4°C (Hazeleger et al., 1998). They are believed to be
sensitive to environmental stressors such as pH, temperature and exposure to high oxygen
concentration (Park, 2002), albeit Campylobacter can survive in a wide range of environmental
conditions and food matrices (Ziprin, 2004). Researchers have proposed that when exposed to
extreme conditions, Campylobacter can go into a viable but nonculturable (VBNC) state which is
characterized by a loss of culturability on routine agar and limiting its detection by conventional
plate count techniques (Rollins and Colwell, 1986; Tholozan et al., 1999). The VBNC cells have
higher physical and chemical resistance than culturable cells, which might be due to their lower
metabolic rate and a cell wall strengthened by increased peptidoglycan cross-linking (Signoretto
et al., 2000). The VBNC state of C. jejuni cells is still a matter of controversy; some researchers
consider this physiological state a degenerative form (Mederma et al., 1991), while others claim
that the VBNC state is a dormant state and the organism be able to resurrect under favorable
conditions (Stern et al., 1994; Baffone et al., 2006).
2.1.2.3 Biofilm Formation
Even though Campylobacter is known to be a fastidious organism under laboratory
conditions, research has shown that this organism is ubiquitous and able to survive in a wide range
of environmental sources such as water, bovine manure, compost, and in frozen poultry products
(Cools et al., 2003; Havelaar et al., 2007; Inglis et al., 2010). Besides the ability of C. jejuni to
form VBNC state, another possible mechanism which Campylobacter may utilize to survive in
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such inhospitable conditions is the ability to produce or to become a part of a biofilm (Buswell et
al., 1998; Reeser et al., 2007; Ica et al., 2012). A biofilm is a collection of either single or multiple
species of surface-associated microbial cells enclosed in a self-produced extracellular polymeric
substance (EPS) matrix (Donlan, 2002; Siringan et al., 2011). Biofilms are beneficial for microbes
as the bacteria in biofilms are known to be > 1,000-fold more resistant to disinfectants and
antimicrobials than their planktonic counterparts, and thus, serve as a mechanism for survival
during stress (Fux et al., 2005; Sofos and Geornaras 2010). There is a paucity in the information
on Campylobacter biofilm formation, and unlike the other foodborne pathogens, the overall
significance of biofilms in the physiology and survival is still not well understood (Plummer,
2012). Campylobacter biofilm formation ability has been studied both in microaerobic and aerobic
condition because oxygen is considered a stress factor for Campylobacter. Reuter and colleagues
(2010) proposed that biofilm formation was increased in the presence of atmospheric oxygen.
Additionally, Campylobacter persistence in the environment in the form of mixed-species biofilms
is more common than in mono-species biofilm as the mixed-species biofilms are more compact
than biofilms with only C. jejuni (Ica et al., 2012; Feng et al., 2016; Teh et al., 2016). The formation
of biofilms in poultry processing plants are of major concern, as they may aid in the survival of C.
jejuni on many food contact surfaces including conveyor belts and stainless-steel tables, which
may serve as potential sources of contamination and possible transmission of the pathogens
through the human food chain (Peyrat et al., 2008; García-Sánchez., 2017; Clarke, 2018).
2.1.2.4 Genes Contributing to Virulence and Survival of C. jejuni in the Host and
Environment
The circular genome of C. jejuni NCTC11168 is 1,641,481 base pairs (30.6% G+C) in
length, 94.3% of the genome code is predicted to encode 1,654 proteins and 54 stable RNA species,
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making it the densest bacterial genome sequenced to date (Parkhill et al., 2000). The average gene
length is 948 base pairs (Parkhill et al., 2000). C. jejuni has several genes that contribute to its
virulence and survival in the host and/or environment. Genes are required for motility (flaA, flaB,
fliA, fliK, fliF, fliM, fliY, flgI, flgH flgE, rpoN), chemotaxis (tlp1, tlp4, tlc10, acfB, cetA, cetB),
adhesion (cadF, capA, jlpA, flpA, peb3 and 4), invasion (ciaB ciaC, cial, iamA), toxin production
(cdtA, cdtB and cdtC), multidrug and bile resistance (cmeA, B and cmeC), stress response (spoT,
katA, aphC sod, cj0358 and 0020) quorum sensing (luxS) have been described by Bolton (2015).
The effective interventions that downregulate the expression of aforementioned genes could have
direct impact on undermining the survival and virulence of C. jejuni in poultry, poultry products
and environment.
2.2 Significance of Poultry/Poultry Products in Human Campylobacteriosis
Campylobacter spp. are widely distributed in most warm-blooded animals, including food
animals such as poultry, cattle, pigs, sheep and ostriches; and in pets such as dogs and cats
(Humphrey et al., 2007). The bacteria have also been found in shellfish (Wilson et al., 1996).
Campylobacter infection in humans have often been reported with the consumption of raw milk,
undercooked poultry meat, contaminated foods, water or handling of animals (CDC, 2018)
Chickens are one of the primary reservoirs of C. jejuni. Chickens get colonized at the age
of 2-3 week with dose as low as 50 organisms (Achen et al., 1998; Knudsen et al., 2006). The
primary site of their colonization is lower gastrointestinal tract, notably ceca where they can grow
up to 108 cfu/g of cecal material (Beery et al., 1988; Stern et al., 1988; Achen et al., 1998). It has
been found that Campylobacter prevalence rate in the United States is up to 93% at the farm level
(Stern et al., 2001; McCrea et al., 2006; Sahin et al., 2015), and the rate greatly varies by seasons,
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regions and production type. Similarly, in the European Union, the Campylobacter prevalence
ranged from 0.6 to 13.1% in the northernmost countries such as Finland, Norway and Sweden, and
up to 80% in the southernmost countries (Newell and Fearnley, 2003; Skarp et al., 2016).
Despite the use of several processing aids in conventional poultry processing plants to
reduce or eliminate foodborne pathogens, Cui and colleagues (2005) reported Campylobacter in
approximately 76% of the organic and 74% of the conventional chicken samples (sampled between
September 2002 to August 2003). Likewise, a recent study conducted by Guyard-Nicodème and
colleagues (2015) found that approximately 76% of the French chicken meat was contaminated by
Campylobacter with the load as high as 5 log10 cfu/g. It has been reported that Campylobacter is
highly prevalent in broiler chickens and often considered as the primary source of food-related
transmission of this bacteria to humans (Skarp et al., 2016). Both the CDC and EFSA (European
Food Safety Authority) have found that chicken meat may directly account for 16% and 20-30%
of human cases respectively (CDC, 2018b; EFSA, 2018).
2.3 Human Infections due to Campylobacter
2.3.1 Campylobacteriosis in Humans
Campylobacter infection in humans (campylobacteriosis) is generally considered as selflimiting illness, with patients showing symptoms of diarrhea, fever, abdominal cramps, nausea and
vomiting. The incubation period is usually 2 to 5 days and the symptoms last about a week. The
incidence of campylobacteriosis has been rising worldwide in the past decade. The number of
cases of Campylobacter infections have increased in developed countries such as North America,
Europe, and Australia (Kaakoush et al., 2015). Campylobacter is the most common diarrheal
illness in the United States, and it is estimated that more than 1.3 million people are affected each
17

year (CDC, 2018a). The average number of outbreaks reported each year from 2004-2009 was 28;
59 from 2010-2012 and 35 from 2013-2015 (CDC, 2018b). Similarly, EFSA estimated that more
than 190,000 human cases of campylobacteriosis annually, with the actual number of cases ~9
million (EFSA, 2018). The OzFoodNet Working Group (2015) reported that the most commonly
notified infections in Australia were Campylobacter (17,733 notifications) followed by Salmonella
(12,271 notifications) in 2011. Kaakoush and colleagues (2015) reported that there was a
significant increase in Campylobacter infections in Asia, Africa and Middle East. Despite of the
limited surveillance data, Campylobacter infections were detected in 21% of hospitalized children
with diarrhea in African countries and approximately 5-15% of gastroenteritis cases in Asia and
the Middle East in the year 2005-2006 (Kaakoush et al., 2015).
2.3.2 Human Infection Associated with Campylobacter
In people with low immunity, Campylobacter occasionally spreads to the bloodstream and
causes life-threatening infections such as Guillain-Barré syndrome and reactive arthritis (CDC,
2018c; WHO, 2018)
2.3.2.1 Guillain-Barré Syndrome
Guillain-Barré syndrome (GBS) was first described in 1916 by three French neurologists
Georges Guillian, Jean-Alexandre Barré and André Strohl in two soldiers with acute areflexic
paralysis followed by recovery (Guillain, 1916; Hughes et al., 2005). The term GBS defines a
clinical entity that is characterized by a rapid onset of progressive limb weakness, tingling in the
extremities, loss of tendon reflexes and muscles functions. The underlying mechanism is due to
biological mimicry between Campylobacter antigens and human gangliosides leading to

18

production of cross-reactive antibodies, which attack the peripheral nerves resulting in loss of
nerve function (Hughes et al., 1997; Olivé et al., 1997; Ang et al., 2004).
Currently GBS is divided into 3 subtypes based upon neurological symptoms related to
different immunological mechanisms (Winer, 2014). The 3 subtypes are listed as: acute
inflammatory demyelinating polyradiculoneuropathy (AIDP); acute motor axonal neuropathy
(AMAN) and acute motor and sensory axonal neuropathy (AMSAN) (van Doorn et al., 2008).
Both AIDP and AMAN are associated with C. jejuni infection; however, axonal neuropathy is
more common (Rees et al., 1995; Ho et al., 1999; Ogawara et al., 2000; Hadden et al., 2001).
GBS is rare, affecting only about 1 in 100,000 people in the United States (CDC 2018d).
Despite the high incidence of C. jejuni infections in the general population, the incidence of GBS
triggered by C. jejuni infection is relatively low. In the United States, it is estimated that 1 in every
1058 Campylobacter infections may lead to GBS (Buzby et al., 1997). The two possible reasons
for such a low incidence of GBS could be: 1) Only a small proportion of C. jejuni strains have
ganglioside mimics on their lipooligosaccharides (Nachamkin et al., 2002); 2) Not all the patients
exposed to C. jejuni generate an antiganglioside response. However, the exact reasons why certain
individuals break tolerance and enter into an auto-reactive state is not well understood (Willison
et al., 2013).
2.3.2.2 Reactive Arthritis
Reactive arthritis (ReA) is a form of seronegative spondyloarthritis, a painful form of joint
inflammation that arises after certain types of gastrointestinal or genitourinary bacterial infections
such as Chlamydia, Salmonella, Shigella, Yersinia and Campylobacter infections (Ahvonen et al.,
1969; Granfors et al., 1989; Carter, 2006; Pope et al., 2007). The relationship between
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development of ReA and Campylobacter infection was first described in late 1970’s (Urman et al.,
1977; Berden et al., 1979; Weir et al., 1979). ReA typically develops within 4 weeks of intestinal
or urogenital infections. The common symptoms of ReA include pain and inflammation of joint,
tendon, skin, mucosa, or eyes (Carter, 2006). The pathophysiology of ReA is still not well
understood and is under intensive research; however, it has been hypothesized that molecular
mimicry between Human Leukocyte Antigen B27 (HLA-B27) and bacterial molecules has been
found in Yersinia (Aho et al., 1974), Shigella (Van Bohemen et al., 1984) and Salmonella
(Hermann et al., 1993). This mimicry could induce tolerance and lack of clearance of these
organisms (Ferreira et al., 2015). Studies have shown that the incidence of ReA following
Campylobacter infection vary widely. A population-based study by Hannu and colleagues (2002)
in Finland from April 1997 to September 1998 suggested the estimated rate of 4.3 per 10,000
infections, while a systematic literature review in Embase, PubMed, and Scopus databases by
Ajene and colleagues (2013) determined it to be 9 per 1000 Campylobacter infections. Unlike in
other rheumatic conditions, nonsteroidal anti-inflammatory drugs are the first-line treatment for
the management of ReA (Carter, 2009). Disease-modifying anti-rheumatic drugs such as
Sulfazalasine are effective for the peripheral manifestations, and use of glucocorticoids in ReA is
contraindicated, except for an occasional intra-articular injection (García-Kutzbach et al., 2018).
2.4 USDA Regulation for Controlling Campylobacter in Raw Chicken
The United States Department of Agriculture Food Safety and Inspection Service (USDA
FSIS) rigorously enforces Campylobacter monitoring and control for poultry (USDA FSIS,
2018a). The Campylobacter verification sampling is conducted in establishments by FSIS
inspection program personnel who will collect samples using routine sampling using a 52-week
moving window approach. Performance standards for broiler carcass and chicken parts require
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that no more than 8 of 51 samples (15.7%) and 4 of 52 (13%) samples respectively be positive for
Campylobacter (USDA FSIS, 2018a). The minimum number of samples should be no less than 10
for broiler carcass and 13 for chicken parts within 52-week moving window. For example, if a
poultry processor tests 26 samples 52-week period and only two samples test positive for
Campylobacter, then the percent positive is 7.69 (2/26)*100 = 7.69%. In this example, the
resulting percent positive (7.69%) is less than 13%, maximum acceptable percent positive for
chicken parts. As such, the establishment would pass the performance standard. A test is
considered positive when any Campylobacter organisms are detected in the samples (USDA FSIS,
2018a).
2.5 Intervention Strategies
Since the farm is the preliminary site of Campylobacter entry and/or contamination,
reduction of Campylobacter-positive flocks, decreasing prevalence and bacterial counts on raw
chicken is the most relevant strategy to reduce the number of human campylobacteriosis cases.
Thus, the major intervention strategies should be targeted at farm level (pre-harvest intervention
strategies). However, currently in conventional poultry production there are no such treatments
which are consistently effective to reduce or eliminate Campylobacter from colonizing the birds
(Lin, 2009). Due to the lack of effective pre-harvest interventions, the need for post-harvest
interventions of pathogen reduction/elimination is of utmost importance (Wagenaar et al., 2015).
Quantitative risk assessment models have indicated that a reduction of C. jejuni counts on a broiler
carcass by 2 log10 units could result in a 30-fold reduction of human incidence (Rosenquist et al.,
2003). Hence, reduction or elimination of Campylobacter in the poultry/poultry products is an
essential step to address this food safety issue. The following post-harvest interventions have been
studied to eliminate/reduce Campylobacter load on chicken carcasses.
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2.5.1 Hauling and Transportation
Feces, feathers, and skin are the main sources of Campylobacter contamination during
transportation and holding. Studies have shown that pathogen colonization increases due to
defecation onto crates and birds, and, the persistence of Campylobacter on the crates is a potential
source of contamination for Campylobacter negative flocks as the crates are reused (Stern et al.,
1995; Slader et al., 2002; Berrang et al., 2004; Gomółka-Pawlicka et al., 2014). Therefore, several
decontamination processes such as washing with hot water (55 to 70°C), forced hot air, high
concentrations of disinfectant (e.g., 1,000 ppm of bleach, 2500 ppm peracetic acid) and physical
scrubbing or ultrasonic treatment have been advised before reuse (El-Assaad et al., 1995; Ramesh
et al., 2004; Allen et al., 2008a; Allen et al., 2008b; Berrang et al., 2011). In addition, Hastings
and colleagues (2011) demonstrated that the number of Campylobacter-positive swabs from silver
ion containing crates were lower when compared with the standard crates obtained after removal
of live birds at the processing plant and across the decontamination process (pre-wash to 3 h postsanitizer).
2.5.2 Preventing Cross-contamination at the Slaughterhouse
Logically it seems ideal to follow certain practices such as, scheduled slaughter (identifying
flocks positive for Campylobacter before slaughter and subjecting carcasses from these flocks to
special treatment) and logistic slaughter (slaughtering positive flocks after negative flocks) to the
slaughtering process to prevent or reduce cross-contamination. However, practically, it may not
be possible, as a high number of birds must be slaughtered per hour and disinfecting the machinery
between every two carcasses or between flocks may not possible (Wagenaar et al., 2006; Umaraw
et al., 2017).
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2.5.3 Interventions at the Poultry Processing Plant
The slaughter of poultry in commercial slaughterhouses is a highly automated and efficient
process. Despite technological advancement, contamination of chicken carcasses during
processing is still a major problem (Seliwiorstow et al., 2015; Althaus et al., 2017). Thus, proper
decontamination of carcasses at processing facilities should not be neglected. Methods to
decontaminate the carcass during processing can be divided into physical, chemical, biological or
the combinations of these technologies (Hugas and Tsigarida, 2008). Importantly these methods
should be cost-effective, environmentally friendly, and easy to implement into the production
scheme and finally not result in negative attributes to the final product (Loretz et al., 2010)
2.5.3.1 Physical Treatments
The objective of these treatments is to remove attached fecal materials and microbial flora
off the whole chicken carcass. Physical methods include but not limited to washing with water,
chilling and irradiation.
2.5.3.1.1 Washing
Washing with potable water has been used extensively in conventional poultry processing
since 1978 and may result in an overall reduction of carcass surface contamination by 90 to 99%
(Dickson and Anderson, 1992). In an attempt to comply with zero tolerance requirements for
visible contamination on carcasses and to meet microbiological performance standards under the
hazard analysis and critical control point (HACCP) final rule (FSIS, 1996), a typical poultry
processing plant (150,000 to 200,000 birds per day) uses 3.7 to 7.5 million liters of water every
day (Sellers and Kiepper, 2001), and spends $500,000 to $1 million per year (Jackson et al., 1999).
Currently, poultry processing plants in the United States utilize warm water to kill bacteria and to
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reduce the surface tension of water for effective removal of microflora and fecal matter (Bashor et
al., 2004). A study by Li and colleagues (2002) observed that hot water spray (60°C) reduced
Campylobacter counts by 0.78 log10 cfu/carcass compared with cold water (20°C) spray. Similarly,
it has been found that carcasses washed with hot water (70°C) for 40 s followed by cold water (1215°C) spray for 10 s produced 1.6 log10 reduction in Campylobacter counts with no negative effect
on chicken skin (Purnell et al., 2004).
2.5.3.1.2 Chilling
Regulations in the United States require poultry carcasses to be cooled (4°C or lower)
rapidly (carcases weighing < 4 lbs, within 4 h of processing; carcasses weight 4-8 lbs, within 6 h;
and those weighing >8 lbs, within 8 h of processing unless such poultry is to be frozen or cooked
immediately at the official establishment) to prevent outgrowth of potential foodborne pathogens
on the products (USDA FSIS, 2014). The most common method of chilling in the United States is
the immersion chilling which is a fast chilling technique and relatively cost effective. In this
process, carcasses are moved through tanks against water current containing a mixture of ice and
cold potable water (Sams, 2000; El-Shibiny et al., 2009). However, the use of other chilling
methods (air-dry systems and evaporative air chillers) have been increased as a consequence of
limited supply of water world-wide, wastewater discharge, and carcass water content (Huezo et
al., 2007). It was reported that feather follicles opened after picking but become closed during
chilling allowing Campylobacter to entrap within them (Berndtson et al., 1992). Nevertheless,
recent study showed that most follicles closed immediately after defeathering (Latt et al., 2018).
Various antimicrobial compounds have been used in immersion tanks to ensure the reduction of
pathogens to a level safe for humans (USDA FSIS, 2018b).
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2.5.3.1.3 Irradiation
It has been proposed that irradiation has the potential to reduce foodborne pathogens in
freshly chilled or frozen poultry products without affecting the organoleptic properties. The high
energy (1.5 and 4.5 kGy) rays of irradiation directly and indirectly damage the DNA of microbes,
effecting their ability to grow or reproduce (CDC, 2001). Xavier and colleagues (2016)
demonstrated that cobalt 60 gamma irradiation at doses of 1.5, 3.0 and 4.5 kGy effectively
eliminated Campylobacter spp. from chilled inoculated chicken hearts. The use of 1.5 to 3 kGy on
fresh or frozen raw packaged poultry products was approved by FDA and USDA (Keener et al.,
2004). Even though antimicrobial properties of irradiation is well documented, this method is
poorly accepted by consumers (MacRitchie et al., 2014; Wagenaar et al., 2015; Xavier et al., 2016).
2.5.3.2 Chemical Treatments
Antimicrobial compounds that are approved by both the FDA and USDA to decontaminate
poultry carcasses are classified as processing aids (National Chicken Council, 2013). The USDA
FSIS provides a list of processing aids with specific information on acceptable levels that are used
in processing plants (USDA FSIS, 2018b). Processing aids which are commonly used by U.S.
poultry processors are discussed below.
2.5.3.2.1 Sodium hypochlorite (Chlorine)
Chlorine has been used in poultry processing for more than five decades throughout the
processing line to reduce spoilage as well as foodborne pathogens (Keener et al., 2004; Oyarzbal,
2005). The USDA has set the recommended levels; 20 ppm in bird washers, 5 ppm in the recycled
water used in the pre-chiller and 50 ppm in the primary chillers (USDA FSIS, 2018b). Earlier
studies have shown the potential use of chlorine as an antimicrobial wash/dip, with only 0.1 mg/L
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of free chlorine being required to inactive 99% of C. jejuni after 5 min of contact (Blaser et al.,
1986). The benefits of being readily available at low cost and low concentration required for
efficacy has resulted in the widespread use of chlorine in processing plants (Keener et al., 2004).
However, recent studies have shown that chlorine has limited efficacy due to its dependence on
the pH of water (ideal pH 6 to 6.5), presence of organic matter and exposure time (Keener et al.,
2004; Oyarzbal, 2005). It has been found that the washer systems containing 25-35 ppm of total
chlorine on average reduced Campylobacter population by 0.5 log10 cfu/mL (Bashor et al., 2004).
Similar results were reported by Suejee and colleagues (2016) where they detected Campylobacter
from ground chicken treated with 50 ppm chlorine
2.5.3.2.2 Chlorine dioxide
Chlorine dioxide is an antimicrobial compound commonly used as a disinfectant and
sanitizer (Keener et al., 2004). It is seven times more effective than chlorine in reducing pathogenic
microorganism which allow it to be effective even at lower concentrations without producing
corrosive action on processing equipment (Lillard, 1979). Bolder and colleagues (2004) reported
a 0.7 log10 reduction of C. jejuni with the application of 4.25 ppm chlorine dioxide. In another
study, 97% C. jejuni cells were damaged when exposed to 20 ppm for 2 min in vitro (Smigic et
al., 2011). It is allowed to be used at levels not to exceed 3 ppm in water that has direct contact
with whole fresh poultry carcasses (USDA FSIS, 2018b).
2.5.3.2.3 Trisodium phosphate
Trisodium phosphate (TSP) is an inorganic, white, crystalline material that complies with
the specifications of the Food Chemical Codex (Keener et al., 2004). The antibacterial effect of
TSP is well known against a wide range of bacteria; however, it is more active against Gram26

negative pathogens such as Salmonella, Campylobacter, and E. coli (Bashor et al., 2004; Keener
et al., 2004). Trisodium phosphate has a pH of 11.8 at a recommended concentration (12% w/v)
for use during pre-chill and post-chill poultry processing. The proposed mechanism of action of
TSP is the high pH of the solution, and surfactant property (Keener et al., 2004). Koolman and coworkers (2014) showed that 12% TSP alone or in combination with organic acids and its salt (citric
acid or capric acid sodium salt) resulted in significant reduction (2-3 log10 cfu/cm2) of C. jejuni
counts on drumsticks. Similar results were observed by Sarjit and colleagues (2015) on chicken
meat under simulated commercial water chilling conditions. Although TSP offers significant antiCampylobacter activity, the use of TSP can be costly and affects the water holding capacity of
meat (Keener et al., 2004).
2.5.3.2.4 Cetylpyridium chloride
Cetylpyridium chloride (CPC) is a cationic quaternary ammonium compound with
antimicrobial activity against a wide range of Gram-negative bacteria (Oyarzabal, 2005). The use
of CPC as a processing aid was approved by the USDA FSIS with the maximum recommended
dose of 0.8% (USDA FSIS, 2018b). It was found that 0.5% (wt/vol) CPC significantly reduced
Campylobacter by >1.0 log10 cfu on chicken breast skin (Arritt et al., 2002). Similarly, Beers and
colleagues (2006) reported significant reduction (0.8 to 2.1 log10) of Campylobacter on pre-chill
carcasses sprayed with a commercial CPC (Cecure®).
2.5.3.2.5 Acidified sodium chlorite (ASC)
The use of ASC was approved by the FDA, EPA and the USDA as an antimicrobial spray
or dip for poultry, red meats, vegetables, fruits and seafood (Kemp et al., 2001). Acidified sodium
chlorite exhibits its antimicrobial property by oxidizing microbial cell components at pH between
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2.3 to 3.3 (Keener et al., 2004). It was found that a post-chill application of ASC reduced
Campylobacter to < 0.2 log10 cfu/mL of carcass rinse (Oyarzabal et al, 2005).
2.5.3.2.6 Organic Acids
Organic acids such as acetic acid, lactic acid, citric acid and succinic acid have been
approved as processing aids in poultry processing (USDA FSIS, 2018b). Unlike chlorine, these
acids are very stable in the presence of organic materials (Keener et al., 2004). The effectiveness
of the organic acids depends upon concentration, temperature and contact time (Dickson and
Anderson, 1992). It was found that carcasses sprayed with 4% lactic acid solution reduced 0.4
log10 cfu/g of C. jejuni on breast skin whereas 8% solution of lactic acid reduced counts by 1.9
log10 cfu/g. However, higher dose of lactic acid adversely affected the meat quality of the carcasses
(Burfoot et al., 2015).
2.5.3.2.7 Peracetic acid
Peracetic acid (PAA) is the peroxide of acetic acid (AA) that has higher oxidation potential
than chlorine thereby offers greater antimicrobial activity against wide variety of microbes. It is
commercially available in the equilibrium mixture of PAA, AA, hydrogen peroxide and water
(Kitis, 2004). Studies have shown that its antimicrobial activity is based on the release of active
oxygen which disrupts the function of cell membrane, denature proteins and inactive catalase
(enzyme required to detoxify free hydroxyl radicals) (Leaper, 1984; Liberti and Notrnicola, 1999;
Kitis, 2004). Peracetic acid has been listed as a processing aid to decontaminate poultry carcasses
and parts in the US poultry industry since 2001 (FDA, 2018). In a survey of U.S. commercial
poultry operations, PAA was the leading chemical intervention (McKee, 2011). In accordance with
the FSIS Directive 7120.1, the upper allowable level of PAA in chiller water is 220 ppm and for
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post-chill dip application is 2000 ppm (USDA FSIS, 2018b). Park and colleagues (2017) showed
that post-chill application of PAA at 1200 ppm reduced Campylobacter counts by 1.5 log10 cfu/g
when compared to water spray. However, there are significant occupational hazards (irritation of
eyes, skin and difficulty in breathing) associated with doses as low as 340 ppm of PAA (Pechacek
et al., 2015).
2.6 Natural Approach to Reduce Foodborne Pathogens on Poultry Products
Most of the processing aids that were discussed above are synthetic or inorganic chemicals.
The emerging problems regarding the negative impact exerted by some synthetic preservatives on
the health of consumers versus the benefits imparted by natural antimicrobials has increased
consumer preference for minimally processed or less chemically treated foods which has turned
more attention to plant derived antimicrobials as an alternative. Finding healing power in plants is
an ancient idea. In recent years, research has focused to explore the potential of plant-derived
antimicrobials as safe and effective antimicrobial treatments for improving food safety (Burt,
2004; Wagle et al., 2017; Mendonca et al., 2018). Plants represent vast resources of antimicrobial
compounds. The antimicrobial compounds in plant materials are commonly found in the essential
oil fraction of different parts (leaves, flowers, buds, bulbs, seeds, or other parts) of plants (Gutierrez
et al., 2008). These antimicrobial compounds contain different chemical groups in their structure
such as alkaloids, terpenoids, polyphenols and sulfur-containing compounds. Thus, these
antimicrobials have different mechanism of actions against microbes, which makes them less
likely to develop resistance by bacteria (Cowan, 1999; Burt, 2004; Savoia, 2012). Several studies
have demonstrated the potential use of plant-derived antimicrobials for controlling C. jejuni on
poultry products (Fisher and Phillips, 2006; Riedel et al., 2009; Wagle et al., 2017). A study
conducted by Fisher and Phillips (2006) found potential use of lemon, orange and bergamot
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essential oils and their components against major foodborne pathogens including C. jejuni in food
systems. Riedel and colleagues (2009) observed 3 log10 cfu/mL reduction in C. jejuni counts after
washing chicken skin with 1.6% grape fruit extract for 1 min. Previously, we observed that chicken
skin or meat washed with β-resorcylic acid derived from angiosperms significantly reduced (2
log10 cfu) C. jejuni counts. Moreover, β-resorcylic acid downregulated genes responsible for
virulence and survival of C. jejuni in the chicken meat juice (Wagle et al., 2017).
2.6.1 Carvacrol
2.6.1 Properties of Carvacrol
Carvacrol (also known as cymophenol) is a moneoterpenooid phenol, which is the major
component of essential oils obtain from oregano (Origanum vulgare), thyme (Thymus vulgais),
pepperwort (Lepidium flavum) and wild bergamot (Lawrence, 1984; Prudent et al., 1995; Russo et
al., 1998; Alagawany et al., 2015). Also, carvacrol has been produced by chemical and
biotechnological synthesis via metabolic engineered microorganisms (More et al., 2007). It is a
GRAS status compound (Code of Federal Regulations 21 part 172) and has been used as a
flavoring agent in sweets, beverages and chewing gum (Nostro et al., 2012; USFDA, 2018). Since
ancient time, plants containing carvacrol have been used for medicinal purpose (Nostro et al.,
2012). It is reported to have a wide variety of biological properties including anti-inflammatory
(da Silva Lima et al., 2013), antioxidant (Quiroga et al., 2015), anti-cancer (Jung et al., 2018),
acetylcholinesterase inhibitor (a therapeutic strategy to treat Alzheimer’s disease; Jukic et al.,
2007), analgesic (Wagner et al., 1986), antihepatotoxic (Uyanoglu et al., 2008), antiparasitic
(Force et al., 2000), insecticidal (Karpouhtsis et al., 1998) and antimicrobial (Preuss et al., 2005;
Ben Arfa et al., 2006). Studies have shown that carvacrol exert significant antimicrobial effect
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against various foodborne pathogens both in vitro and in vivo (Kim et al., 1995; Pol et al 1999; Du
et al., 2008). Kollanoor Johny and colleagues (2010) found that carvacrol significantly reduced
Salmonella Enteritidis and C. jejuni counts in the chicken cecal contents (in vitro). Previous study
from our lab also showed that in-feed supplementation of carvacrol alone or in combination with
thymol significantly reduced C. jejuni counts in 10-day old broiler chickens (Arsi et al., 2014).
2.6.2 Proposed Mechanisms of Action of Carvacrol
The antimicrobial action of carvacrol has been attributed to its considerable effects on the
structural and functional properties of cytoplasmic membrane of microbes. Since carvacrol is a
hydrophobic compound, it interacts with the lipid layer of the cytoplasmic membrane and itself
aligns between the fatty acid chains causing the expansion and destabilization of the membrane
structure leading to disruption of cell permeability (Lambert et al., 2001). It has been demonstrated
that carvacrol reduces ATP synthesis or increases ATP hydrolysis inside the bacterial cell resulting
in rapid depletion of intracellular ATP pool (Ultee et al., 1999). Moreover, it was hypothesized
that carvacrol acts as a trans-membrane carrier of H+ and K+: the undissociated molecule diffuses
inside the cell where it donates a H+ in exchange of K+, then the undissociated ion carrying K+
return via cell membrane into the external environment (Ultee et al., 2002). In the external
environment, it releases K+ and accept H+, and then reenters the cell in the same way. The
repetition of this cycle leads to the change in pH gradient across the bacterial cell, thereby leading
to bacterial cell damage (Ultee et al., 2002).
2.6.1.3 Carvacrol in the Food Industry
Over the last decade, the potential use of carvacrol in the food industry to improve food
safety has been extensively studied. Since carvacrol has multiple health benefits, the incorporation
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of this compound in food products could improve food safety as well as product quality. Burt and
co-workers (2007) found that carvacrol vapor as low as 20% (v/v) in ethanol significantly reduced
Salmonella Enteritidis on raw chicken breast. They also observed that all viable cells (5 × 103 cfu)
were eliminated by vapor concentration above 40% at 37°C. Ravishankar and colleagues (2010)
showed that 1% carvacrol dip treatment of artificially contaminated celery for 10 min reduced
antibiotic-resistant S. enterica counts to below detection (<1 log10 cfu) on day 3. In addition, they
observed 5-log reduction of S. enterica on oysters by day 3. Recently, Nair and colleagues (2015)
reported that carvacrol (0.5, 1, or 2%) reduced Salmonella counts in turkey breast cutlets. They
also found that the combined application of carvacrol (0.25, 0.5, and 1%) treatment for 30 s and
modified atmospheric packaging (95% carbon dioxide and 5% oxygen) resulted in significant
reduction (1 – 2 log10 cfu/g) of both Salmonella and Campylobacter counts on turkey breast cutlets.
It has been found that carvacrol from 0.5 – 1% facilitate thermal destruction of E. Coli O157:H7
in raw ground beef (Juenja et al., 2008).
2.6.1.4 Nanoemulsion Dip Treatments
Many essential oils including carvacrol are inhibitory to foodborne pathogens; however,
high concentrations are needed to observe maximum effect which may potentially affect
organoleptic properties of foods (Nychas, 1995, Burt, 2004). Moreover, essential oils are poorly
soluble in water limiting their application on a commercial scale. Thus, studies using novel
technology to increase the water solubility and antimicrobial activity of essential oils are
warranted. One such technology could be the use of nanotechnology, which has been a promising
strategy to improve the solubility, stability, delivery, antimicrobial efficacy, and masking the
disagreeable taste of hydrophobic phytochemicals. The American National Institute of
Occupational Safety and Health (NIOSH) defined nanotechnology as a “system of innovative
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methods to control and manipulate matter at near atomic scale to produce new materials, structures,
and devices” (NIOSH, 2007). The term nanoemulsions also refers to a colloidal particulate system
in which oil/water/oil dispersion are stabilized by surfactant molecules resulting in a droplet size
range from 20 to 600 nm (Jaiswal et al., 2015). The smaller size and greater surface area is
associated with the increased solubility and stability in water. In addition, smaller size enhances
permeation capacity, thereby, improving antimicrobial efficacy (Gelperina et al., 2005). Recent
studies and reviews on the use of nanotechnology in the food industry have identified the possible
applications of nanotechnologies to improve food safety (Shrivastava et al., 2009; Kour et al.,
2014; Otoni et al., 2014; Landry et al., 2015; Gundewadi et al., 2016, 2018).
2.6.2 Antimicrobial Edible Films and Coatings
In recent years, much attention has been focused on research to replace conventional
packaging materials by biodegradable materials. Edible films and coatings are thin layers that are
coated on the surface of food products. They are not expected to be removed before consumption
and are prepared from various food grade substances including proteins, polysaccharides and
lipids. The concept of edible films and coatings has emerged due to the fact that they can serve as
a barrier to moisture, gas, and flavors thereby limiting losses of volatile flavor compounds,
minimizing deterioration, and extending the shelf-life of food products (Kurt et al., 2017).
The application of edible coatings on poultry products is a part of a multi-hurdle
intervention approach for improving food safety (Gennadios et al., 1997; Biladeau et al., 2009;
Ravishankar et al., 2009; Janes et al., 2012; Fernández-Pan et al., 2014). Currently, researchers are
focusing on enhancing the functionality of the coating treatments by integrating antimicrobial
substances such as essential oils to deliver another level of food safety (Fernández-Pan et al., 2014;
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Noori et al., 2018). The gradual release of the antimicrobial agents from the edible films and
coatings leads to continuous protection of foods from contamination and limits the effect on
sensory quality (Sánchez-Ortega et al., 2014).
2.6.2.1 Gum arabic
2.6.2.1 Overview
Gum arabic, or acacia gum is a natural gum consisting of the hardened sap of various
species of the acacia tree and is composed of a highly branched arrangement of galactose,
arabinose, rhamnose, and glucuronic acids (Anderson et al., 1966; Islam et al., 1997). In traditional
medicine, it has been used for the treatment of chronic kidney diseases in Middle Eastern countries
(Islam et al., 1997; Nasir et al., 2012).
2.6.2.2 Gum arabic in the Food Industry
The FDA (Code of Federal Regulations 21 part 184) has designated gum arabic as a GRAS
multipurpose food ingredient for beverages, chewing gum, confectionaries, dairy products, nuts
and nut products with the percent ranges from 1-85% (FDA, 2018). Gum arabic is an excellent
source of dietary fiber, which is fermentable in the colon to release short-chain fatty acids and has
low energy value (1.7 calories/g) which makes it suitable for food-fortification (Foodnavigatorusa, 2008; Patel and Goyal, 2015). Gum arabic has diverse functions such as enhancement of
vegetable shelf-life, anti-obesity effects, antimicrobial effects, anti-inflammatory and
anticoagulation effects (Patel and Goyal, 2015). It is a well known emulsifier for use in the
essential oil and flavor industries (Montenegro et al., 2012). Different post-harvest studies using
gum arabic on different food matrices have revealed improved shelf-life and food safety. It has
been reported that apples coated with gum arabic improved the shelf-life and quality (El-Anany et
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al., 2009). Similarly, Ali and co-workers (2010) found significant improvement (P < 0.05) on shelflife and post-harvest quality on tomatoes coated with 10% gum arabic when stored at 20°C and 8090% relative humidity for 20 days. Recently, it has been observed that Salmonella Enteritidis
counts were significantly reduced (P < 0.05) on shell eggs when coated with either 10% gum arabic
alone or in combinations with different phytochemicals (carvacrol, eugenol, or β-resorcylic acid)
for 7 days (Upadhyaya et al., 2016).
2.6.2.2 Chitosan
2.6.2.2.1 Overview
Chitosan is a linear aminopolysaccharide, composed of β (1-4) linked D-glucosamine and
N-acetly-D-glucosamine, and derived from chitin (a structural component of crustacean shells). It
has

excellent

properties

such

as

bio-compatibility,

biodegradability,

non-toxicity,

antimicrobial/antifungal, and adsorption (Hudson and Smith, 1998; Dutta et al., 2004). It is
estimated that 6-8 million metric tons of chitin is produced globally each year by seafood
processing (Yan and Chen, 2015). Because of high production of chitosan from the seafood
industry, commercial application of chitin derivatives for coating treatments could be an
economically feasible solution for the management of seafood by-products (Shahidi and
Synowiecki, 1991).
2.6.2.2.2 Proposed Mechanisms of Action of Chitosan
The exact mechanisms of the antimicrobial activity of chitosan are still unknown.
However, it is known that the antimicrobial activity of this compound is governed by several
factors such as, microbial cell age, positive charge density, molecular weight, chelating capacity,
hydrophilic capacity, ionic strength in medium, pH, temperature and reactive time (Kong et al.,
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2010). It has been suggested that the positively charged amino group of chitosan disrupts the
negatively charged cell membrane leading to leakage of cellular contents (Young et al., 1982;
Ganan et al., 2009) and chelation of trace minerals thereby inhibiting the microbial growth (Cuero
et al., 1991). In addition, it also disrupts protein synthesis by binding to the host DNA (Sudarshan
et al., 1992).
2.6.2.2.3 Importance of Chitosan in Poultry/Poultry Product Safety
There has been a growing interest in recent times to develop effective food safety
intervention strategies using chitosan. A post-harvest study conducted by Menconi and colleagues
(2013) demonstrated that Salmonella Typhimurium inoculated chicken skin when dipped in 0.5%
chitosan solution for 30 s significantly reduced the counts at 24 h in comparison to the samples
dipped in phosphate-buffered saline. Moreover, 0.5% chitosan significantly reduced spoilage
bacteria, thus highlighting the role for chitosan in enhancing food safety and improving shelf-life
of poultry products. Likewise, a significant reduction (up to 4 log10 cfu/cm2) was observed in
ready-to-eat turkey deli meat coated with either chitosan-lauric arginate easter or chitosan-nisin
(Guo et al., 2014). Arkoun and colleagues (2018) reported that chitosan-based edible films
extended the shelf-life of chicken breast by one week. Similarly, Souza and co-workers (2018)
showed that chitosan incorporated with ginger essential oil improved the shelf-life of fresh poultry
meat. Our previous studies have shown that in-feed supplementation of 0.5% medium molecular
weight chitosan was effective (P < 0.05) in reducing C. jejuni counts in 14-day old broiler chickens,
and also down-regulated the expression of chicken colonization genes as compared to control
(Arambel et al., 2015). In addition, in our post-harvest studies, we observed significant reduction
(P < 0.05) of C. jejuni counts on chicken wingettes coated with 2% medium molecular weight
chitosan at day 3, 5 and 7 of refrigerated samples. While fortifying the chitosan with caprylic acid
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or lactic acid bacteria, the significant reduction was observed at day 0, 1, 3, 5, and 7 (Woo-Ming,
2015).
2.7 Hypothesis and Objectives of the Dissertation:
Based on published literature and preliminary data, it was hypothesized that natural
compounds (plant/animal-derived) exert significant antimicrobial effect against C. jejuni in postharvest poultry. In addition, those compounds modulate expression of virulence genes of C. jejuni.
The specific objectives of this dissertation were:
1. To investigate the efficacy of carvacrol suspension, emulsion and nanoemulsion as an
antimicrobial wash treatment to reduce C. jejuni counts on chicken skin.
2. To investigate the efficacy of gum arabic or chitosan-based coating fortified with carvacrol to
reduce C. jejuni counts on chicken wingettes.
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1. Abstract
Campylobacter jejuni, a major cause of human gastroenteritis worldwide, is often
associated with the consumption of contaminated poultry products. With increasing consumer
preference to natural and minimally processed foods, interventions utilizing natural antimicrobials
for controlling C. jejuni on poultry products is gaining popularity. This study investigated the
efficacy of the generally recognized as safe compound, carvacrol (CR) as a wash treatment in
reducing C. jejuni and aerobic bacteria on chicken skin. Two separate studies, each with two trials
were conducted. In the first study, the efficacy of CR suspension (0, 0.25, 0.5, 1 and 2%) was
investigated, whereas in the second, the efficacy of CR as emulsion and nanoemulsion was studied.
In both studies, skin samples were inoculated with 50 μL (~8 log10 cfu/sample) of a cocktail of
four wild strains of C. jejuni. After 30 min of attachment, inoculated skin samples were washed
with the respective treatments for 1 min, subjected to drip dry for 2 min and processed at 0, 8, 24
h post treatment for enumeration of C. jejuni and aerobic bacterial counts (n=5/treatment/time
point). In addition, the effect of treatments on the color of chicken skin was evaluated. The data
were analyzed by ANOVA using PROC MIXED procedure of SAS 9.3. All the tested doses of CR
suspension consistently reduced C. jejuni counts across all time points. The 2% CR wash was the
most effective treatment and reduced C. jejuni counts by ~4 log10 cfu/sample (P < 0.05). In
addition, 1% and 2% CR significantly reduced aerobic counts (up to 2 log10 cfu/sample) at all time
points. The results from the second study suggest that anti-Campylobacter efficacy of CR emulsion
or nanoemulsion treatments were not improved compared to CR suspension. Several CR
suspension treatments were more effective than corresponding emulsion and nanoemulsion
treatments. No significant difference in colors of skin samples between treatments was observed
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(P > 0.05). The results suggest that CR could potentially be used as an antimicrobial wash treatment
in post-harvest poultry.
Key words: Campylobacter jejuni, carvacrol, emulsion, nanoemulsion, chicken skin
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2. Introduction
Campylobacter infection in humans is one of the most common bacterial foodborne
diseases worldwide (WHO, 2017). In the United States, Campylobacter causes an estimated 1.3
million illnesses each year. However, the actual figure might be higher as many cases go
undiagnosed or unreported (CDC, 2017). Campylobacter jejuni accounts for 90% of human
campylobacteriosis cases characterized by vomiting, bloody diarrhea, abdominal cramps and fever
(WHO, 2017). In certain cases, campylobacteriosis leads to serious sequelae such as, reactive
arthritis and Guillain-Barré syndrome (Spiller, 2007; Gradel et al., 2009) that could lead to death.
It was estimated that the annual cost associated with campylobacteriosis is approximately 1.9
billion dollars (Hoffmann et al., 2015). Surveys of raw agricultural products support epidemiologic
evidence implicating undercooked and contaminated chicken meat as one of the primary sources
for human C. jejuni infection (Kramer et al., 2000). Poultry are the reservoir for C. jejuni wherein
the pathogen colonizes at high level (108 cfu/g of cecal material) in the lower gastrointestinal tract
(Blaser et al., 1983; Evans, 1991; Wagenaar et al., 2015) leading to product contamination during
slaughter and poultry processing.
Commercial poultry processors have implemented various Hazard Analysis and Critical
Control Points and good manufacturing practices to lower the pathogen load on carcasses,
however, potential for contamination exists in the farm to fork supply chain (Elvers et al., 2011;
Alonso-Hernando et al., 2013). Campylobacter spp. was isolated from up to 76% of retail organic
chicken meat and 74% of conventional chickens collected from retail stores in Maryland between
September 2002 and August 2003 (Cui et al., 2005). A more recent study by Williams and Omar
(2012) observed that the average prevalence of Campylobacter spp. in skinless boneless retail meat
from 2005 through 2011 in Alabama, USA was 41%. With a growing population and increasing
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consumer awareness, the consumption of poultry meat has tripled over the last 5 decades. (USDAFAS, 2018). As a result of the high consumption rate of poultry meat and greater prevalence of C.
jejuni on retail poultry products, the risk of C. jejuni infections in humans is substantial (Nauta et
al., 2007; Marder et al., 2017).
A number of studies have been conducted for controlling C. jejuni in poultry with varied
degree of success (Byrd et al., 2001; Cole et al., 2006; Arsi et al., 2014; Guyard-Nicodeme et al.,
2015; Shrestha et al., 2017; Wagle et al., 2017; Huneau‐Salaün et al., 2018 ). As part of multihurdle approach to control foodborne pathogens, research is being focused on developing safer
and effective post-harvest interventions for controlling C. jejuni on poultry products. Various
interventions including physical methods such as freezing, chilling, hot, steam and electrolyzed
water treatments, ultrasound, and irradiation, have been tested to reduce the pathogen counts on
carcasses (Patterson, 1995; Park et al., 2002; Corry et al., 2007; James et al., 2007; Musavian et
al., 2014). In addition, chemicals such as organic acids, chlorine or phosphate-based compounds
have been used as chemical decontaminant with pathogen reduction ranging from 1 to 2.2 log10
(Zhao and Doyle, 2006; Bauermeister et al., 2008; Riedel et al., 2009; Birk et al., 2010; Loretz et
al., 2010; Thormar et al., 2011). However, potential concerns with regards to change in the meat
quality, reduced consumer acceptance and cost of treatments has made most of the aforementioned
treatments less applicable for decontaminating poultry carcasses at industrial setting (Dawson et
al., 1963; Cox et al., 1974; Bilgili et al., 1998; Whyte et al., 2003). To address this, researchers are
focusing on using natural plant-derived antimicrobials for carcass decontamination (Smith-Palmer
et al., 1998).
The antimicrobial properties of various essential oils in the food system is well documented
in the literature (Chouliara et al., 2007; Sharma et al., 2017). Carvacrol [2-Methyl-5-(160

methylethyl) phenol] is a monoterpenic phenol biosynthesized from γ-terpinene. This phenolic
compound is the major component of the essential oil fraction of oregano (Arrebola et al., 1994).
Carvacrol (CR) is currently listed as generally recognized as safe (GRAS) by the U.S. Food and
Drug Administration (Code of Federal Regulations 21 Part 172). Carvacrol exhibits a plethora
of biological activities including broad spectrum antimicrobial action (Ultee et al., 2000; Xu et
al., 2008; Kollanoor Johny et al., 2010), antioxidant (Aeschbach et al., 1994; Ramos et al.,
2014), anticancer (Arunasree, 2010; Mehdi et al., 2011; Luo et al., 2016) and antifungal
properties (Lima et al., 2013; Chavan and Tupe, 2014). Previous studies from our lab and
collaborators have demonstrated the efficacy of CR against C. jejuni in vitro studies on cecal
contents (Kollanoor Johny et al., 2010) as well as in vivo studies in 10-day old broiler chickens
(Arsi et al., 2014); however, CR as an antimicrobial wash treatment for reducing C. jejuni in
post-harvest poultry has not been investigated.
Despite multiple benefits, the use of essential oils as a natural antimicrobial in food
systems is limited primarily due to flavor concern and need for high concentrations to exert
their antimicrobial effect. Moreover, CR has low water solubility. Albeit, the total surface area,
solubility, and the antimicrobial property of CR could be enhanced by using
emulsion/nanoemulsion technology (Landry et al., 2014, 2015; Yadav et al., 2014). We
hypothesized that CR could reduce both C. jejuni and aerobic counts on poultry products and
could be used as an effective antimicrobial treatment to improve food safety. In addition, we
also hypothesized that CR emulsion and nanoemulsion would result in greater bacterial
reductions than CR suspension alone.
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The present study investigated the efficacy of CR (suspension, emulsion, nanoemulsion)
as an antimicrobial wash to reduce C. jejuni and aerobic bacteria on chicken skin. In addition,
the effect of aforementioned treatments on the color of chicken skin was investigated.
3. Materials and Methods
Bacterial Strains and Culture Conditions
Four wild-type strains (S1, S3, S4 and S4) of C. jejuni were used for this study. The C.
jejuni inoculum for each trial was prepared as described by Shrestha and colleagues (2017).
Briefly, one loopful of glycerol stock of each strain was inoculated into separate 15 mL tube
containing 5 mL of sterile Campylobacter Enrichment Broth (CEB; catalogue no. 7526A, Neogen
Corp, Lansing, MI) followed by incubation at 42°C under microaerophilic atmosphere (5% O2,
10% CO2, and 85% N2) for 48 h. After incubation, C. jejuni strains were sub-cultured for 24 h and
centrifuged at 3500 × g for 10 min. The cell pellet was resuspended in 20 mL of Butterfield’s
Phosphate Diluent (BPD; 0.625 mM potassium dihydrogen phosphate, pH 6.67) and used as
inoculum.
Study 1: Evaluation of Antimicrobial Activity of CR Suspension on Chicken Skin
Preparation of CR Suspension Treatments. For the preparation of CR suspension, 2%
(vol/vol) stock suspension of CR (catalogue no. W224502, Sigma-Aldrich Co., St. Louis, MO)
was made in sterile BPD followed by stirring at 300 rpm for 15 min. Two-fold concentrations of
the stock solution were made in BPD to obtain 0.25, 0.5 and 1% CR suspension. The pH of all the
treatment solutions were ~6.6.
Preparation, inoculation and treatments of chicken skin samples. Chicken thighs were
procured form the University of Arkansas Poultry Pilot Processing Plant (Fayetteville, AR). The
skin was removed from the muscle tissue, cut into pieces (4 cm × 4 cm) and stored at -20°C until
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the day of experiment. A total of 150 skin samples were used for two trials. For each trial, 75 skin
samples were randomly allocated to 5 treatments (0, 0.25, 0.5, 1 and 2% CR; n=5 samples per
treatment per time point). Each skin sample was inoculated with 50 µL (~8 log10 cfu/sample) of a
cocktail of four wild strains of C. jejuni and allowed to adhere for 30 min. Inoculated skin samples
were washed with 25 mL of respective treatment solutions for 1 min, drip dried for 2 min and were
processed either immediately (0 h) or after 8 or 24 h of storage at 4°C.
Microbial Analysis. For the sample processing, each skin sample was transferred in 10 mL
of Dey-Engley neutralizing broth (catalogue no. C7371, Hardy diagnostic, Santa Maria) and
vortexed at 700 rpm for 15 s. The sample was 10-fold diluted in BPD and plated using the spread
plate technique onto Campylobacter Line agar (CLA; Line, 2001) for C. jejuni enumeration and
tryptic soy agar (TSA; catalogue no. C7121, Hardy diagnostics, Santa Maria, CA) for aerobic
bacteria enumeration. The inoculated CLA or TSA plates were incubated at 42°C for 48 h under
microaerophilic atmosphere or at 37°C for 24 h under aerobic condition respectively. Bacterial
colonies were expressed in log10 cfu/sample.
Study 2: Comparative Antimicrobial Evaluation of CR Suspension, Emulsion and
Nanoemulsion on Chicken Skin
Preparation of CR emulsion and nanoemulsion. All the compounds used for the
preparation of emulsion and nanoemulsion were designated as GRAS by the FDA. Emulsion was
prepared by using spontaneous emulsification procedure as described previously (Ostertag et al.,
2012) with minor modifications. Briefly, an organic phase was made by adding CR (30 mL) and
Tween-80 (37.5 mL) (catalogue no. 01516, Chem-impex int’l inc., Wood Dale, IL) followed by
stirring using a magnetic stirrer at 750 rpm for 30 min. Sodium phosphate buffer (5mM; pH 7.0;
Sigma-Aldrich) was added into organic phase at the rate of 4 mL/min with continuous stirring for
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1 h. Emulsion solutions were stored at 4°C until needed. The final concentration of CR in the
emulsion was 10% which was then diluted in BPD to prepare 0.25, 0.5, 1 and 2% CR emulsion.
The preparation of nanoemulsion was based on the optimized system as described by
Chang et al. (2013) and Abd-Elsalam and Khokhlov (2015) with some modification. Briefly, a
coarse emulsion of CR (15 mL), Tween-80 (30 mL) and buffer (255 mL) was prepared as described
above and mixed for 30 min. The mixture was then sonicated using an ultrasonicator (Qsonica
Q700, Newtown, CT, USA) for 10 min. The stock solution was 5% CR, which was further diluted
in BPD to obtain 0.25, 0.5, 1 and 2% CR nanoemulsion.
Characterization of emulsion and nanoemulsion. The droplet size, zeta potential and
polydispersity index (PDI) of emulsion and nanoemulsion was measured using previously
published method (Zainol et al., 2012; Abd-Elsalam and Khoklov, 2015). Briefly, 10 µL of
emulsion or nanoemulsion was diluted with 1 mL of deionized water at room temperature. Three
replicates of independent batches were analyzed by a dynamic light scattering method using Zetasizer Nano ZS (Malvern Instruments Ltd, Malvern, WR, UK). The thermodynamic stability of
freshly prepared emulsion and nanoemulsion was determined using standard published method
(Shafiq and Shakeel, 2010; Abd-Elsalam and Khoklov, 2015). Briefly, the solutions were
centrifuged at 3500 × g for 20 min to evaluate the phase separation. In addition, four cycles of
heating and cooling were performed between 4°C and 40°C to study the effect of temperature on
the stability of emulsion and nanoemulsion.
Preparation, inoculation and treatments of chicken skin samples. A total of 450 skin
samples were used for two replicate trials. For each trial, 225 skin samples were randomly divided
into 15 treatment groups consisting of baseline, BPD, Tween-80 and four doses (0.25, 0.5, 1 and
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2%) of CR suspension, emulsion and nanoemulsion respectively (n=5 samples per treatment per
time point). Chicken skin samples were prepared and inoculated followed by wash treatments as
described in Study 1. The sample processing and enumeration of C. jejuni and total aerobic bacteria
were conducted according to the procedure described above. Additionally, C. jejuni counts in the
wash solution (post-treatment) was determined by plating 250 µL wash treatment on CLA plates
followed by incubation as described previously.
Determination of Color
The color measurements of skin samples treated with CR suspension, emulsion or
nanoemulsion were carried out using a chroma meter (CR-300, Konica Minolta Sensing Inc.,
Japan) and this was used to objectively measure International Commission on Illumination (CIE)
L*, a*, b* values (L* measure relative lightness, a* relative redness and b* relative yellowness).
Two replicate trials were conducted. For each trial, 150 samples were randomly divided into 15
treatment groups (as described above) for two time points (0 and 24 h). The instrument was
calibrated against white tile before measurements were recorded. Three readings were taken on
the lateral side of each sample.
Statistical Analysis
For the microbial analysis, C. jejuni and aerobic bacteria counts (cfu/sample) were
transformed to log10 cfu/sample to maintain the homogeneity of variance (Byrd et al., 2001). For
the color analysis, data from two trials were pooled for each treatment before analysis. The data
were analyzed using ANOVA with the PROC MIXED procedure in the SAS statistical software,
version 9.3 (SAS Institute Inc., Cary, NC). Means were partitioned by LSMEANS analysis, and a
P value of < 0.05 was required for statistical significance.
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4. Results
Properties and stability of CR emulsion and nanoemulsion
The average particle size (Z-average), PDI and zeta-potential for emulsion were ∼505.6 ±
101, 1± 0.12 and -24.9 ± 11.3 mV respectively, whereas for nanoemulsion the values for average
particle size (Z-average), PDI and zeta-potential were ∼260.3 ± 25 nm, 0.039 ± 0.01 and -18.7 ±
5.54 mV respectively. The distribution was unimodal. The solutions were stable after
centrifugation at 3500 × g for 20 min, and resisted four cycle of heating and cooling.
Antimicrobial efficacy of CR suspension against C. jejuni and aerobic bacteria on chicken skin
The effect of CR on C. jejuni. Figure 1 shows the effect of CR suspension in reducing C.
jejuni on inoculated chicken skin stored at 4°C for three different time points (0, 8 and 24 h). The
C. jejuni counts present on the control (skin washed with BPD) was ~5.5 and ~6 log10 cfu/sample
for the trial 1 and 2 respectively. All the tested doses of CR suspension (0.25, 0.5, 1 and 2%)
significantly reduced C. jejuni counts (> 1.4 log10 cfu/sample) compared to the controls. Two
percent CR suspension reduced C. jejuni by 3.22 log10 cfu/sample at 0 h in trial 1 and ~4.0 log10
cfu/sample at 0 h in trial 2 when compared with the controls. All the doses of CR suspensions
(0.25, 0.5, 1 or 2%) were equally effective in reducing C. jejuni counts when compared among
each other at all storage time points in trial 1. Similar patterns were observed in trial 2 at 24 h,
however, 2% CR suspension was more effective in reducing C. jejuni counts than 0.25 or 1% dose
at 0 h.
The effect of CR on aerobic bacteria. Figure 2 shows the efficacy of CR in reducing
aerobic bacterial counts on the chicken skin. The aerobic bacterial counts recovered from the
controls ranged from ~3.5 to 5 or from 4 to 4.5 log10 cfu/sample for trial 1 and 2 respectively. The
1 and 2% CR suspension consistently reduced aerobic bacterial counts (> 0.93 log10 cfu/sample)
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across all time points in trial 1 (P < 0.05). In the trial 2, the consistent reduction across time points
was observed with 0.5, 1 and 2% doses. In addition, 0.5, 1 and 2% doses were not significantly
different in efficacy among each other in both trials.
Comparative antimicrobial efficacy of CR suspension, emulsion and nanoemulsion against C.
jejuni and aerobic bacteria on chicken skin
The effect of CR on C. jejuni. The effect of CR suspension, emulsion and nanoemulsion
on the survival of C. jejuni on chicken skin is presented in Table 1. C. jejuni recovered from
baseline (skin samples not subjected to treatments) was ~7 log10 cfu/sample. Washing of the skin
samples in either BPD (control for CR suspension) or Tween-80 (control for CR emulsion or
nanoemulsion) reduced C. jejuni counts by ~1 to 1.5 log10 cfu/sample when compared with the
baseline across all time points in both trials (P < 0.05). All doses of CR (0.25, 0.5, 1 or 2%)
suspension significantly reduced C. jejuni counts when compared with its control (BPD) in both
trials. The 2% CR suspension treatment was the most effective and reduced C. jejuni counts by at
least ~3 log10 cfu/sample at 0 h in both trials. Most of the tested doses of CR emulsion and
nanoemulsion significantly reduced C. jejuni counts at 0, 8 and 24 h of storage when compared to
Tween-80 (control) in both trials with the exception of 0.5% CR emulsion or nanoemulsion in trial
1, and 0.25 % CR nanoemulsion in trial 2. When the CR suspension was compared with the
respective doses of either emulsion or nanoemulsion, no consistent difference in efficacy among
the three different forms of CR was observed (except 1% CR suspension versus 1% CR
nanoemulsion). When the CR emulsion versus nanoemulsion were compared within time points
and doses, the 0.25 and 0.5% CR emulsions produced efficacy similar to the respective doses of
nanoemulsion in both trials.
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The effect of CR on aerobic bacteria. The total aerobic bacterial counts (Table 2)
recovered from baseline was ~5.5 and 4.3 log10 cfu/sample in trial 1 and 2 respectively. Washing
of skin sample with either BPD or 4% Tween-80 did not reduce aerobic counts in either trial when
compared to the baseline (P > 0.05). Most of the CR suspension treatments significantly reduced
aerobic counts as compared to the BPD controls in both trials (except for CR 0.25% at 0 and 24 h
in trial 2). The 1% CR emulsion or 2% CR nanoemulsion in trial 1 and only 0.5% emulsion in trial
2 significantly reduced aerobic counts as compared to the baseline (P < 0.05), however, when
compared with the 4% Tween-80, none of the treatments of either emulsion of nanoemulsion
consistently reduced total aerobic counts in both trials ( P > 0.05). When the CR suspension was
compared with the respective doses of either emulsion or nanoemulsion, there was no consistent
difference in efficacy among the three different forms of CR. The efficacy of CR emulsion and
nanoemulsion were similar in majority of time points in both trials.
Survival of C. jejuni in CR wash treatments
Table 3 shows the survival of C. jejuni in the various wash treatments. The number of C.
jejuni surviving in BPD wash treatments ranged from ~5.75 to 6.35 log10 cfu/mL in trial 1 and
from ~6.13 to 6.50 log10 cfu/mL in trial 2. In case of the 4% Tween-80 solution, the number of C.
jejuni was similar when compared with BPD (P > 0.05). However, C. jejuni counts were reduced
to below detection limit (0.6 log10 cfu/mL) in all CR wash treatments.

Effect of CR treatments on the color of skin
Table 4 shows the effect of CR suspension, emulsion or nanoemulsion on the color of skin
stored at 4°C for 0 and 24 h. Samples washed with control (BPD) showed lightness( L*) , redness
(a*) and yellowness (b*) values of 74.80 ± 1.54, 2.27 ± 0.57 and 10.80 ± 0.70 respectively for 0 h
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and 77.8 ± 0.76, 1.68 ± 0.49 and 10.08 ± 0.50 respectively for 24 h. None of the suspensions,
emulsions or nanoemulsions of CR significantly changed the L*, a* and b* of samples at 0 h or at
24 h of storage.
5. Discussion
With increasing consumer demand for natural, antibiotic free and minimally processed
foods, the use of GRAS status plant-derived compounds is gaining more attention as safe and
effective antimicrobials for decontamination of poultry carcass. The rough surface of chicken skin
facilitates attachment and survival of C. jejuni during the multiple stages of processing (Wempe
et al., 1983; Corry and Atabay, 2001; Stern et al., 2001; Tan et al., 2014). Therefore, we used
chicken skin as a model to represent the whole carcass for testing the efficacy of CR against C.
jejuni.
Currently, peracetic acid (1000 ppm) and chlorine (50 ppm) are the most frequently used
chemicals for carcass decontamination by poultry processors (USDA FSIS, 2017), however, the
aforementioned chemicals results in minimal reduction of C. jejuni (Bauermeister et al., 2008;
Nagel et al., 2013). In our preliminary trial, chlorine (50 ppm) and peracetic acid (1000 ppm)
wash treatments reduced C. jejuni on chicken skin by ~0.34 and 1.75 log10 cfu/sample
respectively (data not shown). In the present study, we observed that CR as an antimicrobial
wash treatment significantly reduced C. jejuni counts on chicken skin. The reduction was up to 4
log10 cfu/sample for 2% CR compared with the samples washed in BPD controls (Figure 1).
Similar results were reported previously against various pathogens on other foods. Ultee and
coworkers (2000) reported that CR showed a dose dependent inhibition of Bacillus cereus in
artificially inoculated cooked rice. Antibiotic-resistant Salmonella enterica was significanlty
reduced on celery (below detection limit; detection limit < 1 log10) on day 0 and oysters (~5 log10)
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on day 3 washed in 1% CR for 10 min or 1 h (Ravishankar et al., 2010). Upadhyay and coworkers
(2014) showed that dipping (for 1 and 3 min) of cantaloupes rind plugs in 2% CR alone or in
combination with 2% hydrogen peroxide significantly reduced Listeria monocytogenes on
cantaloupes by > 2.0 to 2.5 log10. The group also observed that CR with hydrogen peroxide reduced
L. monocytogenes to undectable level (detection limit < 1 log10/cm2) with the 10 min dipping time
at 25°C. Recently, a study demonstrated that three common foodborne pathogens (Escherichia coli
O157:H7, Listeria monocytogenes and Salmonella Tyhphimurium) were significantly reduced on
beef when immersed in 0.3 or 0.5% CR with teriyaki sauce after 1, 3, and 7 days stored at 4°C
(Moon et al., 2017). The reduction of C. jejuni on inoculated chicken skin by CR shows its
potential to be used as a natural safe chemical decontamination of chicken carcasses in processing
plants.
Since meat and meat products are very perishable foods and require protection from
microbial spoilage, the meat industry is constantly looking for intervention strategies to increase
the shelf-life and safety of meat products. The use of a GRAS compound that reduces both
foodborne pathogens and spoilage organisms could be a good option to improve safety and quality
of food products. Many studies have been conducted using oregano oil to control spoilage
microorgansims thereby increasing shelf-life of perishable foods (Chouliara et al., 2007; Mexis et
al., 2009; Karabagias et al., 2011). Since most of the meat spoilage bacteria are either aerobic or
facultative anerobic (Gill and Greer, 1993), we evalutated the efficacy of CR against total aerobic
bacteria. Data from our study showed that 1% and 2% CR suspension significantly reduced (P <
0.05) aerobic bacterial counts when compared to the controls (Figure 2). The maximum reduction
(~2.5 log10 cfu/sample) was obtained with 2% CR. Thus, CR could be used to inhibit the growth
of meat spoilage organisms and thereby increasing the shelf-life of poultry products.
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Although the majority of the essential oils are categorized as GRAS (Kabara, 1991), their
use in the food products are greatly limited due to their flavor consideration and limited solubility
in water. Recently, several studies have shown that formulation of emulsion and nanoemulsion
significantly improved the water solubility and alter the antimicrobial efficacy of essential oils
against various microorganisms (Donsì et al., 2011, 2012; Ghosh et al., 2013; Bhargava et al.,
2015; Speranza et al., 2015). The oil in water nanoemulsion consists of a fine dispersion of ultrasmall oil particles with diameter smaller than 400 nm (Arbor et al., 2008), whereas, emulsion
(macro-emulsions) is characterized by particle size of 0.5 to 100 µm (Windhab et al., 2005). The
decrease in oil droplet size in a colloidal solution leads to an increase in the total surface area for
interaction between essential oils and bacteria thereby potentially enhancing the antimicrobial
efficacy of essential oils (Solans et al., 2005; Weiss et al., 2009). Previous studies have explored
the antimicrobial efficacy of CR emulsion and/or nanoemulsion against Salmonella Enteritidis,
Escherichia coli O157: H7 (Landry et al., 2014, 2015) and Lactobacillus plantarum (Char et al.,
2016). However, studies investigating CR emulsion/nanoemulsion efficacy against C. jejuni have
not been conducted. Stable formulation of CR emulsion [surfactant-to-oil ratio (SOR)=1.25] and
nanoemulsion (SOR=2) were selected from various SOR based on our priliminary experiments
(Data not shown). The droplet size in CR nanoemulsion was more uniform than emulsion based
on PDI (0.039 ± 0.01 vs 1 ± 0.12). However, the emulsion or nanoemulsion formulations did not
enhance the antimicrobial efficacy of CR against C. jejuni on chicken skin samples versus the
suspension alone (Table 1). In fact, for several CR suspension treatments, the anti-Campylobacter
efficacy was found to be better in suspension than emulsion or nanoemulsion formulations. One
potential possiblity is the formation of transient, small droplets of CR (with increased surface area
and efficacy) in the CR suspension while the treatments are vigrously shaken at washing step. This
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could increase anti-Campylobacter efficacy of CR suspension. C. jejuni was not detected in the
CR wash treatements (Table 3) indicating that the wash treatments would not lead to
environmental contamination with C. jejuni.
The type of microorganisms that colonize fresh meat products depend highly on the
characteristics of meat, processing methods and storage conditions (Huis in’t Veld, 1996). In
addtion to the better anti-Campylobacter activity of CR suspension over emulsion or
nanoemulsion, we observed the effects of CR suspension is promising against aerobic bacteria
when compared with other two forms of CR (Table 2).
The color of poultry carcasses and poultry meat products is one of the important attributes
of product quality because it is directly related to the purchasing decision of consumers. The
lightness value, L*, represents the darkest black at L* = 0, and the brightest white at L* = 100.
The -a* to +a* and -b* to +b* represent green-red and blue-yellow respectively (Pathare et al.,
2013). We did not observe a significant change (P > 0.05) in the color values (L*, a* and b*) either
at 0 or 24 h after washing with CR suspension, emulsion or nanoemulsion treatments when
compared with the controls (BPD or Tween-80) or baseline (Table 4). These results indicate that
CR treatments could be used as a potential wash treatment to reduce the load of C. jejuni and meat
spoilage bacteria without changing chicken skin color.
In conclusion, CR suspension, emulsion and nanoemulsion as a wash treatment produced
a consistent reduction in C. jejuni counts on chicken skin. The reduction (~4 log10 cfu/sample) by
the highest dose of CR suspension is promising since a 2-log10 reduction of Campylobacter on the
poultry carcass could reduce the risk of human campylobacteriosis by up to 30-fold (Rosenquist
et al., 2003). In addition, CR suspension reduced aerobic bacteria counts without changing the
color of chicken skin. Thus, CR treatments could be a good alternatives of conventional chemicals
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to reduce the Campylobacter and meat spoilage bacteria on the chicken carcasses; however,
follow-up investigations testing the effects of CR should be conducted in an industrial setting prior
to implementing these treatments in the poultry processing plant.
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Figure 1: Evaluating the efficacy of carvacrol suspension (0, 0.25, 0.5, 1, and 2% CR) as a wash treatment against C. jejuni on chicken
skin. Inoculated chicken skin samples (~8 log10 cfu/sample) were washed in treatment solution for 1 min followed by drip dried for 2
min and processed at 0, 8 or 24 h of refrigerated storage. In each trial, “a-c” designates the statistical difference among the treatments
within the same time points (P < 0.05). Values (log10 cfu/sample) presented as mean ± standard error of mean).
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Figure 2: Evaluating the efficacy of carvacrol suspension (0, 0.25, 0.5, 1, and 2% CR) as a wash treatment against total aerobic bacteria
on chicken skin at 0, 8 or 24 h of refrigerated storage. In each trial, “a-c” designates the statistical difference among the treatments
within the same time points (P < 0.05). Values (log10 cfu/sample) presented as mean ± standard error of mean).
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Table 1: Effect of carvacrol suspension, emulsion and nanoemulsion on Campylobacter jejuni
survival on chicken skin1, 2
Trial Treatments
Baseline
Controls

BPD
4% Tween-80

0h
7.52 ± 0.01a
6.32 ± 0.11bc
6.55 ± 0.06b

Time points
8h
7.25 ± 0.06a
6.17 ± 0.15b
6.07 ± 0.11b

24 h
7.28 ± 0.03a
5.79 ± 0.05bc
5.83 ± 0.04b

0.25%
5.08 ± 0.15ef
4.50 ± 0.13g
3.80 ± 0.07gh
0.50%
4.86 ± 0.12fg
4.88 ± 0.23efg
3.42 ± 0.08hi
Suspension
1%
4.40 ± 0.22g
4.77 ± 0.39fg
3.16 ± 0.27ij
2%
3.49 ± 0.54h
3.69 ± 0.40h
2.80 ± 0.27j
1
0.25%
5.53 ± 0.10de
4.93 ± 0.12defg 4.99 ± 0.08de
0.50%
5.23 ± 0.07ef
5.71 ± 0.09bc
4.68 ± 0.09ef
Emulsion
1%
5.07 ± 0.08ef
5.46 ± 0.22cd
4.38 ± 0.08f
2%
4.43 ± 0.10g
5.45 ± 0.17cd
3.22 ± 0.33ij
0.25%
5.96 ± 0.08cd
5.29 ± 0.12cdef 5.36 ± 0.17cd
0.5%
5.24 ± 0.08ef
5.63 ± 0.16bc
4.93 ± 0.15de
Nanoemulsion
1%
5.25 ± 0.04ef
5.48 ± 0.19cd
3.90 ± 0.17g
2%
4.95 ± 0.13f
5.42 ± 0.17cde
3.91 ± 0.12g
Baseline
7.10 ± 0.07a
7.31 ± 0.06a
7.08 ± 0.02a
BPD
5.91 ± 0.09b
5.86 ± 0.08b
5.74 ± 0.08b
Controls
4% Tween-80 6.03 ± 0.07b
5.76 ± 0.09b
5.70 ± 0.10b
0.25%
4.98 ± 0.09cd
4.56 ± 0.14e
4.26 ± 0.30ef
0.50%
4.17 ± 0.21f
3.82 ± 0.25fg
4.18 ± 0.24efg
Suspension
1%
4.15 ± 0.18f
3.57 ± 0.26g
2.69 ± 0.28i
2%
2.46 ± 0.53g
3.53 ± 0.09g
3.33 ± 0.23h
0.25%
5.00 ± 0.17cd
4.98 ± 0.15cd
4.94 ± 0.06cd
2
0.50%
4.70 ± 0.18de
4.50 ± 0.06e
4.26 ± 0.18ef
Emulsion
1%
4.26 ± 0.11ef
4.00 ± 0.12f
3.93 ± 0.24fg
2%
4.26 ± 0.11f
4.02 ± 0.21f
3.96 ± 0.26fg
0.25%
5.49 ± 0.10bc
5.15 ± 0.13c
5.14 ± 0.10c
0.5%
5.00 ± 0.15cd
4.54 ± 0.12e
4.39 ± 0.18ef
Nanoemulsion
1%
4.79 ± 0.07de
4.67 ± 0.06de
4.51 ± 0.10de
2%
4.30 ± 0.12ef
3.83 ± 0.14fg
3.70 ± 0.08gh
1
n = 5 replicates per treatment per time point per trial. Values (log10 cfu/sample) presented as mean
± standard error of mean).
2
C. jejuni counts within column in the same trial with no common superscript differ significantly
(P < 0.05).
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Table 2: Effect of carvacrol suspension, emulsion and nanoemulsion against aerobic bacteria
counts on chicken skin1, 2
Trial

Treatments
Baseline
Controls

Suspension
1
Emulsion

Nanoemulsion
Baseline

BPD
4% Tween-80
0.25%
0.50%
1%
2%
0.25%
0.50%
1%
2%
0.25%
0.5%
1%
2%

0h
5.76 ± 0.07a
5.78 ± 0.09a
5.58 ± 0.09ab
4.88 ± 0.15cde
4.66 ± 0.22e
4.67 ± 0.36de
3.95 ± 0.15f
5.61 ± 0.11ab
5.33 ± 0.08abc
4.89 ± 0.29cde
4.57 ± 0.26e
5.57 ± 0.06ab
5.76 ± 0.07a
5.01 ± 0.2cde
5.16 ± 0.11bcd
4.23 ± 0.08ab
3.89 ± 0.09bcde
3.78 ± 0.08bcde
4.10 ± 0.20b
2.65 ± 0.18gh
2.93 ± 0.29fg
2.18 ± 0.12h
3.93 ± 0.22bcd
3.50 ± 0.17de
3.40 ± 0.07ef
4.24 ± 0.34ab
4.05 ± 0.23bc

Time points
8h
5.43 ± 0.19a
4.86 ± 0.15ab
4.67 ± 0.11bcd
3.93 ± 0.19efg
3.54 ± 0.46fg
3.52 ± 0.22fg
3.43 ± 0.41g
4.04 ± 0.3defg
4.24 ± 0.28bcdef
4.12 ± 0.32cdefg
4.87 ± 0.15ab
4.71 ± 0.44abcd
4.40 ± 0.15bcde
4.78 ± 0.22abc
4.62 ± 0.19bcde
4.31 ± 0.06a
3.85 ± 0.11abc
4.16 ± 0.24ab
3.14 ± 0.19de
2.34 ± 0.16f
2.26 ± 0.26f
2.46 ± 0.14f
3.54 ± 0.11cd
3.00 ± 0.14e
3.97 ± 0.17abc
3.98 ± 0.19abc
4.03 ± 0.27abc

24 h
5.15 ± 0.06a
4.90 ± 0.22ab
4.87 ± 0.26ab
3.19 ± 0.30e
3.66 ± 0.23de
3.47 ± 0.21e
4.11 ± 0.22cd
4.28 ± 0.10c
4.85 ± 0.22ab
4.37 ± 0.33bc
4.55 ± 0.09bc
5.23 ± 0.07a
4.19 ± 0.11cd
4.40 ± 0.03bc
4.45 ± 0.15bc
4.29 ± 0.11a
4.14 ± 0.20ab
4.02 ± 0.08abc
3.71 ± 0.24abc
2.91 ± 0.29de
2.67 ± 0.24ef
2.31 ± 0.2f
3.52 ± 0.12c
2.91 ± 0.26de
3.61 ± 0.06bc
3.44 ± 0.30cd
4.16 ± 0.16ab

BPD
4% Tween-80
0.25%
0.50%
Suspension
1%
2%
2
0.25%
0.50%
Emulsion
1%
2%
0.25%
0.5%
3.73 ± 0.10bcde 3.67 ± 0.08bc
3.76 ± 0.09abc
Nanoemulsion
1%
3.56 ± 0.02cde
3.92 ± 0.22abc
3.92 ± 0.25abc
2%
4.71 ± 0.23a
3.86 ± 0.15abc
3.88 ± 0.28abc
1
n = 5 replicates per treatment per time point per trial. Values (log10 cfu/sample) presented as mean
± standard error of mean).
2
Aerobic bacteria counts within column in the same trial with no common superscript differ
significantly (P < 0.05).
Controls
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Table 3: Effect of different doses of carvacrol on survival of Campylobacter jejuni in wash
treatments1,2
Trial Treatments

0h
8h
24 h
BPD
6.11 ± 0.09
5.75 ± 0.15
6.35 ± 0.22
Controls
4% Tween-80 5.98 ± 0.09
5.80 ± 0.11
6.40 ± 0.26
0.25%
ND
ND
ND
0.50%
ND
ND
ND
Suspension
1%
ND
ND
ND
2%
ND
ND
ND
0.25%
ND
ND
ND
1
0.50%
ND
ND
ND
Emulsion
1%
ND
ND
ND
2%
ND
ND
ND
0.25%
ND
ND
ND
0.5%
ND
ND
ND
Nanoemulsion
1%
ND
ND
ND
2%
ND
ND
ND
BPD
6.13 ± 0.09
6.37 ± 0.11
6.50 ± 0.20
Controls
4% Tween-80 6.11 ± 0.08
5.98 ± 0.24
6.31 ± 0.08
0.25%
ND
ND
ND
0.50%
ND
ND
ND
Suspension
1%
ND
ND
ND
2%
ND
ND
ND
0.25%
ND
ND
ND
2
0.50%
ND
ND
ND
Emulsion
1%
ND
ND
ND
2%
ND
ND
ND
0.25%
ND
ND
ND
0.5%
ND
ND
ND
Nanoemulsion
1%
ND
ND
ND
2%
ND
ND
ND
1
n = 5 replicates per treatment per time point per trial. Values (log10 cfu/mL) presented as mean ±
standard error of mean). Within the same trial at the same time, BPD and 4% Tween-80 were not
significantly different (P > 0.05).
2
ND = below detection limit, detection limit ≥ 0.6 log10 cfu/mL
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Table 4: Color values of chicken skin samples treated with carvacrola
Sampling Treatments
time
Baseline

L*

a*

b*

74.78 ± 0.60 2.06 ± 0.16 10.18 ± 0.40
BPD
74.80 ± 1.54 2.27 ± 0.57 10.80 ± 0.70
Controls
4% Tween-80 75.22 ± 0.64 2.02 ± 0.14 10.40 ± 0.31
0.25%
76.10 ± 0.46 2.44 ± 0.41 10.18 ± 1.03
0.50%
76.86 ± 0.81 2.43 ± 0.30 9.85 ± 0.92
Suspension
1%
74.28 ± 0.51 2.74 ± 0.26 10.93 ± 0.71
2%
73.81 ± 0.82 2.09 ± 0.33 10.70 ± 0.54
0.25%
0h
75.06 ± 1.10 1.83 ± 0.09 9.70 ± 1.03
0.50%
75.13 ± 1.94 1.81 ± 0.46 9.17 ± 0.79
Emulsion
1%
73.99 ± 1.55 1.88 ± 0.21 9.61 ± 0.77
2%
73.73 ± 1.40 2.24 ± 0.34 10.43 ± 0.97
0.25%
75.40 ± 1.30 1.70 ± 0.31 9.69 ± 1.03
0.50%
74.95 ± 1.40 2.34 ± 0.82 9.88 ± 0.49
Nanoemulsion
1%
74.95 ± 0.98 1.76 ± 0.19 9.35 ± 0.61
2%
75.16 ± 0.96 1.72 ± 0.23 11.00 ± 0.78
Baseline
76.80 ± 0.39 1.69 ± 0.11 9.30 ± 0.39
BPD
77.80 ± 0.76 1.68 ± 0.49 10.08 ± 0.50
Controls
4% Tween-80 76.76 ± 0.73 1.78 ± 0.16 9.46 ± 0.30
0.25%
78.93 ± 0.67 2.43 ± 0.35 10.31 ± 0.50
0.50%
79.14 ± 0.85 2.36 ± 0.59 10.48 ± 1.15
Suspension
1%
78.83 ± 0.50 1.36 ± 0.50 9.66 ± 0.31
2%
78.89 ± 0.38 1.33 ± 0.84 10.68 ± 0.39
0.25%
24 h
77.68 ± 1.37 1.26 ± 0.50 9.45 ± 0.90
0.50%
77.51 ± 2.57 1.47 ± 0.39 9.00 ± 1.87
Emulsion
1%
77.65 ± 0.98 1.75 ± 0.39 9.88 ± 0.93
2%
76.60 ± 0.56 1.79 ± 0.17 10.44 ± 0.65
0.25%
76.05 ± 1.12 1.41 ± 0.30 9.23 ± 1.04
0.50%
76.96 ± 1.98 1.90 ± 0.41 8.93 ± 0.66
Nanoemulsion
1%
77.48 ± 1.31 1.57 ± 0.42 9.97 ± 0.98
2%
76.02 ± 0.86 1.48 ± 0.46 9.39 ± 1.04
a
n= 5 replicates per treatment per time. Values (means ± standard error of the mean). Within the
same column at the same time, none of the treatments were significantly different with the controls
(BPD or 4% Tween-80) or baseline (P > 0.05).
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Chapter 4
Edible coatings fortified with carvacrol reduce Campylobacter jejuni on chicken wingettes
and modulate expression of select virulence genes
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1. Abstract
Campylobacter jejuni is a leading cause of foodborne disease in humans, and associated
primarily with consumption of contaminated poultry and poultry products. Intervention strategies
aimed at reducing C. jejuni contamination on poultry products could significantly reduce C. jejuni
infection in humans. Antimicrobial edible coatings are increasingly being used by food producers
to prevent food contamination against pathogens. This study evaluated the efficacy of gum arabic
(GA) and chitosan (CH) fortified with carvacrol (CR) as an antimicrobial coating treatment for
reducing C. jejuni on chicken wingettes. Aforementioned compounds are generally recognized as
safe (GRAS) status compounds obtained from gum arabic tree, crustaceans and oregano oil
respectively. A total of four separate trials were conducted in which wingettes were randomly
assigned to baseline (no coating), saline control (wingettes washed with saline), GA (10%), CH
(2%), CR (0.25, 0.5 or 1%) or their combinations. Each wingette was inoculated with a cocktail of
four wild-type strains of C. jejuni (~7.5 log10 cfu/sample). Following 1 min of coating in
aforementioned treatments, wingettes were air dried (1 h) and sampled at 0, 1, 3, 5 and 7 days of
refrigerated storage for C. jejuni and total aerobic counts (n = 5 wingettes/treatment/day). In
addition, the effect of treatments on wingette color was measured using a Minolta colorimeter.
Furthermore, the effect of treatments on the expression of C. jejuni survival/virulence genes was
evaluated using real-time quantitative PCR. Results showed that all three doses of CR, CH or GAbased coating fortified with CR reduced C. jejuni from day 0 through 7 by up to 3.0 log10
cfu/sample (P < 0.05). The antimicrobial efficacy of GA was improved by CR and the coatings
reduced C. jejuni by ~1 to 2 log10 cfu/sample at day 7. In addition, CH-CR coatings reduced total
aerobic counts when compared with non-coated samples for a majority of the storage times. No
significant difference in the color of chicken wingettes was observed between treatments.
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Exposure of pathogen to sublethal concentrations of CR, CH or combination significantly
modulated select genes encoding for energy taxis (cetB), motility (motA), binding (cadF) and
attachment (jlpA). The results suggest that GA or CH-based coating with CR could potentially be
used as a natural antimicrobial to control C. jejuni in post-harvest poultry products.
Key words: Campylobacter, Carvacrol, Gum Arabic, Chitosan, Poultry, Antibiotic alternative
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2. Introduction
Campylobacter jejuni infection in humans continues to be a significant public health
problem throughout the world (WHO, 2018). In the United States, Campylobacter causes 1.3
million illnesses each year and is often associated with consumption of contaminated chicken meat
(CDC, 2018). Epidemiological studies have shown that up to 70% to 80% of retail raw chicken
meat in the United States is contaminated with Campylobacter (Cui et al., 2005). Recently, the
incidence of Campylobacter in the United States surpassed that of Salmonella (17.43 vs 16.66 per
100,000 people; Marder et al., 2017). The high level (107/g of cecal content) of Campylobacter in
the ceca of market age birds (Beery et al., 1988) leads to potential carcass contamination at
processing plants thereby posing a serious public health threat. The concerns are further raised due
to the low infective dose (∼500 cells; Black et al., 1988) required to cause infection in humans and
potentially fatal sequelae such as Guillain-Barré syndrome (Rhodes and Tattersfield, 1982).
Conventional poultry processing constitutes several steps (scalding, picking, evisceration,
chilling) that reduces but does not eliminate Campylobacter contamination on carcasses (Elvers et
al., 2011; Alonso-Hernando et al., 2013). In addition, poultry processors in the United States
heavily rely on the use of inorganic/synthetic chemicals, such as peracetic acid, trisodium
phosphate and chlorine-based compounds to reduce poultry carcass contamination (Keener et al.,
2004; Oyarzabal, 2005; McKee, 2011). However, with increasing consumer demand for safe,
natural and minimally processed foods, the use of natural, plant-derived antimicrobials with
generally recognized as safe (GRAS) status is gaining attention for improving safety of poultry
products. These compounds are naturally derived metabolites and/or by-products from various
plants sources and have been used as the chief source of antimicrobials in human medicine for
thousands of years (Solecki, 1975; Fabricant and Farnsworth, 2001). The antimicrobial activity of
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several plant-derived compounds has been documented (Nychas, 1995; Savoia, 2012). Carvacrol
(CR; 5-isopropyl-2-methylphenol) is a polyphenolic compound which is present in the essential
oil fractions of oregano (60 to 74% carvacrol) and thyme (45% carvacrol) (Lagouri et al., 1993).
Studies have shown that this compound has significant antibacterial properties against a wide range
of foodborne pathogens including Salmonella spp. (Kim et al., 1995; Kollanoor Johny et al., 2010;
Mattson et al., 2011), Campylobacter jejuni (Ravishankar et al., 2008), Listeria monocytogenes
(Upadhyay et al., 2015), E. coli O157:H7 (Du et al., 2008), and Bacillus cereus (Ultee et al., 2002).
Additionally, recent studies have shown that CR can potentially reduce carcinogenesis, suggesting
that CR could be used to reduce the proliferation of cancer cells (Özkan et al., 2011; Jayakumar et
al., 2012; Suntres et al., 2015). Carvacrol is currently listed as GRAS by the U.S. Food and Drug
Administration (Code of Federal Regulations 21 part 172).
Over the last decade, significant research on the use of antimicrobial films or coating
materials for improving microbiological safety and shelf-life of food products has been
undertaken (Dutta et al., 2009; Valencia-Chamorro et al., 2011). The application of
antimicrobial edible coatings onto the surface of raw poultry carcass could be an alternative to
reduce foodborne pathogens including Campylobacter on poultry products. Antimicrobial
edible coatings, due to their presence on products, reduces the chance of cross-contamination
during storage and handling. Gum arabic (GA) is obtained from the gum arabic tree (Acacia
senegal or Senegalia senegal) and is composed of a highly branched arrangement of simple
sugars galactose, arabinose, rhamnose, and glucuronic acids (Anderson and Stoddart, 1966;
Street and Anderson, 1983; Phillips, 1998; Nussinovitch, 2009). The mixture of polysaccharides
and glycoproteins gives GA the properties of a glue and binder which is edible for humans.
Since it is safe for human consumption, it is one of the most commonly used natural coatings
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for various food surfaces and has been used in variety of food preparations such as soft drink
syrup, hard gummy candies, marshmallows and nougats (Foodnavigator-usa, 2008; Dauqan and
Abdullah, 2013; Patel and Goyal, 2015; FDA, 2018). Pharmaceutical drugs and cosmetics also
use the gum as a binder, emulsifying agent and a thickening agent (Smolinske, 1992). In
addition, wine makers have used GA as a wine fining agent (Vivas et al., 2001). Recently, the
use of GA as a coating to improve shelf-life as well as safety of different food products has
been studied. Ali and colleagues (2010) found that 10% GA coating enhanced shelf-life and
improved post-harvest quality of tomatoes. Upadhyaya and co-workers (2016) found that 10%
GA fortified with different phytochemicals (carvacrol, eugenol or β-resorcylic acid)
significantly reduced Salmonella Enteritidis counts on shell eggs. Similarly, chitosan (CH), a
polysaccharide obtained from crustaceans, is another compound that has been extensively
studied as an antimicrobial coating on food products and employed as an effective antimicrobial
for reducing various foodborne pathogens including Listeria monocytogenes (Upadhyay et al.,
2015), Salmonella Typhimurium (Menconi et al., 2013) and Campylobacter jejuni (Woo-Ming,
2015). The CH-based coatings are non-toxic, non-polluting, biodegradable, edible, and are easy
to use in industry setting (Kong et al., 2010; Aider, 2010; Sánchez-González et al., 2011; Elsabee
and Abdou, 2013). Both GA and CH are classified as GRAS by the U.S. FDA for use in foods
(Code of Federal Regulations 21 part 184, 170).
The aim of the present study was to investigate the anti-Campylobacter effect of 10%
GA or 2% medium molecular weight (MMW) CH coatings fortified with CR (0.25, 0.5 and 1%)
on inoculated chicken wingettes. In addition, the effect of the aforementioned treatments on the
color of chicken wingettes was evaluated. The effect of select treatments on the expression of
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genes critical for the survival of C. jejuni in the environment and virulence was also
investigated.
3. Material and Methods
3.1. C. jejuni inoculum preparation
Four wild-type strains (S-1, S-3, S-4, and S-8) of C. jejuni, previously isolated by our
laboratory were used in this experiment. C. jejuni inoculum was prepared as described by Shrestha
and others (Shrestha et al., 2017). Briefly, one loopful of glycerol stock of the wild-type strain C.
jejuni was inoculated into 5 mL of Campylobacter Enrichment Broth (CEB; catalogue no. 7526A,
Neogen Corp, Lansing, MI) and incubated at 42°C in a microaerophilic atmosphere (5% O2, 10%
CO2, and 85% N2) for 48 h. Each strain was sub-cultured again at the same temperature and
atmospheric conditions for 24 h. Sub-cultured C. jejuni was centrifuged at 3500 × g for 10 min,
the supernatant discarded and the cell pellet from each strain was mixed and resuspended in
required volume of Butterfield’s Phosphate Diluent (BPD; 0.625 mM potassium dihydrogen
phosphate, pH 6.67). The resulting suspension was used as inoculum (final bacterial concentration
was ∼8.5 to 9.0 log10 cfu/mL). The bacterial count in the four-strain cocktail was confirmed by
plating 100 μL of culture suspension and its 10-fold dilution on Campylobacter line agar (CLA;
Line, 2001) followed by incubation at 42°C in a microaerophilic atmosphere for 48 h.
3.2. Wingette sample preparation
Chicken wings were procured from the University of Arkansas Poultry Processing Plant
(Fayetteville, AR). The middle portion (wingette) of the whole wing was separated by cutting on
shoulder and elbow joints. Separated wingettes were stored at -20°C until the day of experiment.
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3.3. CR suspension/wash treatment preparation
Carvacrol (catalogue no. W224502, Sigma-Aldrich Co., St. Louis, MO) was suspended in
appropriate volume of sterile BPD solution to obtain 0.25, 0.5, 1% CR suspension in BPD. For
example, 2 mL of CR was suspended in 198 mL of sterile BPD to get 1% CR suspension. The
suspension was stirred at 300 rpm for 15 min before loading to sterile Whirl-PakTM bag (catalogue
no. 018126C, Nasco, Fisher Scientific, Suwanee, GA).
3.4. Coating treatment preparation
The GA (catalogue no. G9752, Sigma-Aldrich CO., St. Louis, MO) coating solution was
prepared based on previously published article (Upadhyaya et al., 2016) with slight modification.
In brief, 10 g of GA were added to 100 mL of sterile BPD. The solution was then stirred for 1 h at
room temperature. Similarly, 2% MMW CH (190 – 310 kDa) (catalogue no. 448877, SigmaAldrich, St. Louis, MO) solution was prepared by using the method developed by Woo-Ming
(2015). Briefly, 2 g of MMW CH powder was dissolved in 100 mL of 50 mM acetic acid (catalogue
no. A38C212, Fisher Scientific, Fair Lawn, New Jersey) solution by stirring overnight at room
temperature. To these coating solutions, required amounts of CR were added and mixed
continuously for 12 h at room temperature to prepare 0.25, 0.5, and 1% coating treatments with
CR.
3.5. Evaluation of antimicrobial activity of coating treatments on chicken wingettes
Coatings of the chicken wingettes was based on the protocol by Woo-Ming (2015). A total
of two trials were conducted in the coating experiment with GA. In each trial, 225 thawed
wingettes were individually inoculated with 50 µL (∼7.5 log10 cfu/sample) C. jejuni and were
allowed to adhere for 30 min. Wingettes were randomly divided into nine different treatment
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groups which included baseline, BPD (wash control), 10% GA (coating control), CR (0.25, 0.5
and 1%) or CR (0.25, 0.5 and 1%) + 10% GA. Each wingette was individually placed in a sample
bag containing 10 mL of the respective treatment for coating/dipping. Working with one treatment
group at a time, wingettes were vigorously shaken/massaged for 1 min to obtain a complete
coating. After coating/dipping, wingettes were removed from bags and allowed to dry for 1 h (30
min on each side). Wingettes were divided into sampling times (n = 5/treatment/time) at days 0,
1, 3, 5 or 7. To process the day 0 samples, microbial analysis was done immediately after drying
while other wingettes were vacuum sealed by a commercially available vacuum sealer (Ziploc®
V201, Lake Barrington, IL) and store at 4°C until the day of sampling. The antimicrobial effect of
CH coating with CR was evaluated as described above. In each trial, the treatments were baseline,
BPD (wash/dip control), 50 mM acetic acid (CH control), 2% CH (coating control), CR (0.25%,
0.5% and 1%) or CR (0.25%, 0.5% and 1%) + 2% CH. For each treatment, 5 wingettes were tested
per time point (n = 5/treatment/time)..
3.6. Microbial analysis
For all experiments, the samples were individually removed from vacuum packaging and
aseptically transferred to a stomacher® 400 classic bag (catalogue no. BA6041, Steward Ltd.,
Worthing, West Sussex, UK) containing 30 mL of Dey-Engley neutralizing broth (catalogue no.
C7371, Hardy diagnostic, Santa Maria) followed by blending for 30 s at 250 rpm (Stomacher®
400 Circulator, Steward Ltd., Worthing, West Sussex, UK). For all samples ten-fold dilutions were
prepared from initial dilution in sterile BPD. Each dilution was surface plated onto CLA followed
by incubation at 42°C microaerophilically for 48 h. For aerobic bacterial enumeration each dilution
was plated onto tryptic soy agar (TSA; catalogue no. DF0369176, Becton, Dickinson and
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Company, Sparks, MD) followed by incubation at 37°C for 24 h. Bacterial colonies were counted
and expressed as cfu/sample.
3.7. Color analysis
Color of wingettes was measured as described by Wagle et al. (2017b). International
Commission on Illumination (CIE) L* (lightness), a* (redness), and b* (yellowness) values for
each wingette were evaluated using a Minolta colorimeter (CR-300, Konica Minolta Sensing Inc.,
Japan). The instrument was calibrated against a white tile before the measurements. Three readings
were taken on the lateral surface of each wingette, averaged and analyzed.
3.8. RNA extraction, cDNA synthesis, and real-time quantitative PCR
The effect of sub-inhibitory concentrations of CR (0.002%), CH (0.0125%) or CR
(0.002%)+CH (0.0125%) combination on expression of selected virulence genes of C. jejuni was
determined using a previously published method (Wagle et al., 2017b) with slight modification.
Briefly, frozen whole chicken carcasses were obtained from the University of Arkansas poultry
pilot processing plant (Fayetteville, AR) and thawed at 4°C for 12 h. The meat exudate was
collected into sterile centrifuged tubes followed by centrifugation at 3,000 × g for 20 min. The
debris were removed, and the juice was filter sterilized with different size filters (0.8, 0.45 and
finally through 0.2-µm cellulose acetate membrane (catalogue no. 28151261 (0.8-µm), 10035088
(0.4-µm), 14224474 (0.2-µm), VWR International, West Chester, PA). C. jejuni S-8 was incubated
in chicken juice with or without sub-inhibitory concentrations of CR, CH or CR+CH at room
temperature for approximately 1 h under aerobic condition. Total RNA was extracted using RNA
mini kit (catalogue no. 12183018A, Invitrogen, Carlsbad, CA, USA). DNase treatment (catalogue
no. 18068015, Thermo Fisher Scientific, Carlsbad, CA, USA) was done followed by the
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complementary DNA (cDNA) preparation using iScript cDNA synthesis kit (catalogue no.
1708890, Bio-Rad Laboratories, Inc., Hercules, CA). All the primers in this study (Table 1) were
designed from published Gene Bank C. jejuni sequences using Primer 3 software (National Center
for Biotechnology Information) and obtained from Integrated DNA Technologies. The cDNA was
used as the template for PCR reaction and the amplified product was detected by SYBR Green
reagent (catalogue no. 1708880, iQ SYBR Green Supermix, Bio-Rad). Data were normalized to
endogenous control (16S rRNA) and expression of candidate genes were analyzed using
comparative critical threshold method on Quant Studio 3 real-time PCR system (Applied
Biosystem, Thermo Fisher).
3.9. Statistical analysis
The bacterial counts were log10 transformed (log10 cfu/sample) for analysis to achieve
homogeneity of variance (Byrd et al., 2001). For the gene expression analysis, data were pooled
and expressed as log10 of relative quantification (RQ) and were analyzed using ANOVA with the
PROC MIXED procedure in SAS statistical software, version 9.3 (SAS Institute Inc., Cary, NC).
Means were partitioned by LSMEANS analysis, and a P < 0.05 was required for statistical
significance.
4. Results
4.1. Efficacy of GA-based or CH-based coating treatments (with or without CR) in reducing C.
jejuni on chicken wingettes
Table 2 shows the effect of 10% GA coating alone or fortified with CR (0.25, 0.5 or 1%)
in reducing C. jejuni on chicken wingettes. The C. jejuni counts recovered from the baseline group
(inoculated wingettes group not subjected to any treatment) ranged from ~6.3 to 7.0 log10
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cfu/sample. In both trials, samples washed with the BPD control showed significant reduction (~1
log10 cfu/sample) of C. jejuni counts from day 0 through day 7, when compared to the baseline
group. As BPD has no anti-Campylobacter property, the observed reduction was probably due to
washing away of loosely attached C. jejuni cells by the solution. Coating with the 10% GA showed
consistent reduction (P < 0.05) in C. jejuni counts when compared to the baseline group, however,
did not show significant difference with the BPD control in both the trials. All the tested doses of
CR (0.25, 0.5 or 1%) significantly reduced C. jejuni counts from day 0 to day 7 in both the trials
when compared with the BPD control. There was significant difference in anti-Campylobacter
efficacy between 0.25% CR and 1% CR in trial 1, however, the results were not consistent between
trials. The combination groups of 10% GA with different doses of CR (0.25, 0.5 or 1%)
consistently reduced C. jejuni counts at all days in both trials when compared to the 10% GA
control (P < 0.05). For example, addition of 1% CR in GA produced additional reduction in C.
jejuni counts by ~1.8 log10 cfu/sample (trial 1) and ~1.2 log10 cfu/sample (trial 2) at day 0 as
compared to the GA alone. The difference in antimicrobial efficacy persisted during the storage
period between GA and combination treatments. The anti-Campylobacter efficacy of GA-CR
coating treatments was similar on majority of storage time points in both trials when compared
with the respective doses of CR alone.
In an attempt to test the effect of different edible coatings fortified with CR, further testing
was done with 2% CH as a coating material (Table 3). As shown in Table 3, the number of C.
jejuni recovered from the baseline group ranged from ~6.1 to 6.7 log10 cfu/sample in trial 1 and
~6.6 to 7.3 log10 cfu/sample in trial 2. The BPD control significantly (P < 0.05) reduced the C.
jejuni counts by ~1 log10 cfu/sample at days 3 and 5 in trial 1, whereas in trial 2, the counts were
significantly reduced throughout the sampling days when compared to the baseline. The number

102

of C. jejuni recovered from skin samples treated with the 50 mM acetic acid solution (with adjusted
pH ~6.4) was not significantly different when compared with the C. jejuni counts recovered from
samples washed with the BPD (except at day 1 in trial 2). The 2% CH coating consistently reduce
C. jejuni counts in both trials as compared to baseline counts. When compared with its control (50
mM acetic acid solution), the 2% CH consistently reduced C. jejuni counts by ~1 to 1.5 log10
cfu/sample, except at day 0 in trial 2 (P < 0.05). As observed in table 2, all the tested doses of CR
(0.25, 0.5 and 1%) significantly reduced C. jejuni counts from day 0 through 7 in both trials when
compared with the BPD control (P < 0.05). The combination treatments were more effective than
CH alone at select time points, however, a consistent improvement in the antimicrobial efficacy
was not observed. For example, all the combination treatments were more effective than CH at
day 1 in trial 1 and at day 0 in trial 2. However, by day 7, the combination treatments and CH
coating were similar in their efficacy in reducing C. jejuni. A similar pattern was observed when
the combination treatments were compared with CR. Only select combination treatments showed
increased efficacy as compared to CR alone at various stages during refrigerated storage. For
example, the combination of lowest dose (0.25%) of CR and CH increased antimicrobial efficacy
by ~0.5 log as compared with the 0.25% CR at days 3 and 7 in trial 1 and days 1 and 7 in trial 2.
The 0.5% CR+CH combination was more effective than 0.5% CR treatment at days 1, 5 and 7 in
trial 1 and at days 1 and 5 in trial 2. The combination of highest dose (1%) of CR with CH had
increased efficacy at days 1 and 3 in trial 1; however, had decreased efficacy at day 3 in trial 2.
The combination treatment was similar to corresponding CR treatments on rest of the storage days
in both trials.
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4.2. Efficacy of GA-based or CH-based coating treatments (with or without CR) in reducing
aerobic bacterial counts on chicken wingettes
Table 4 shows the effect of GA (10%), CR (0.25, 0.5 or 1%) and their combinations on the
total aerobic counts on chicken wingettes. The total aerobic counts recovered from the baseline
group was ~5.34 log10 cfu/sample and ~4.24 log10 cfu/sample at day 0 in trial 1 and 2 respectively.
By the end of the storage, we observed that the aerobic counts in baseline group increased by ~3.33
log10 cfu/sample in trial 1 and ~4.46 log10 cfu/sample in trial 2. The BPD washing did not
significantly reduce aerobic bacterial load except for minimal reductions of ~0.5 log10 cfu/sample
at days 5 and 7 in trial 1 when compared to the baseline. The 10% GA coating did not exert any
antimicrobial effect on the aerobic bacteria. The total aerobic counts recovered from the samples
coated with 10% GA was similar to baseline, except for minimal reduction at day 7 in trial 1.
Among the 3 CR treatments, only 1% CR wash treatment consistently reduced total aerobic counts
by ~0.5 to 1 log10 cfu/sample as compared to the BPD control in both trials and all sampling days
(except day 5 in trial 1). The combination treatments of GA and CR did not differ in their efficacy
in reducing total aerobic counts when compared to either GA or CR on majority of sampling days.
The effect of CH (2%), CR (0.25, 0.5 and 1%) and their combinations on the total aerobic
counts on chicken wingettes is presented in Table 5. As observed in Table 4, the total aerobic
counts in baseline group increased from day 0 through day 7 by ~2 to 3 log10 cfu in both trials.
Unlike the 10% GA, the 2% CH showed significant reduction on the total aerobic counts at all
sampling days expect day 3 in trial 1 when compared to either baseline or BPD control. In trial 2,
the reduction of aerobic bacteria with 2% CH was consistent throughout all sampling days. When
compared to the 50 mM acetic acid solution, the 2% CH significantly reduced the total aerobic
counts at days 0, 5 and 7 in trial 1, and days 1 and 3 in trial 2. The combination treatments of CR

104

and CH produced microbial reductions on majority of sampling days (except day 3 in trial 1; days
0 and 7 in trial 2) when compared with the BPD and baseline. However, the combination treatments
were not significantly more effective than the respective doses of CR or CH alone for majority of
the timepoints.
4.3. The effect of treatments on the color of chicken wingettes
The treatment of chicken wingettes with GA (10%), 50 mM acetic acid (pH ~6.5), CH
(2%), CR (0.25, 0.5 or 1%), or combinations did not produce significant changes on the color
values (L*, a*, b*) of wingettes when compared with either BPD control or baseline group (Tables
6a, 6b and 6c) within the same sampling day. The refrigerated storage had no significant effect on
the lightness of chicken wingettes. At the end of 7 days of storage, the redness of wingettes did
not significantly differ from day 0 and day 3 in all treatments except baseline and 1% CR. Majority
of treatments did not affect yellowness (b*) during refrigerated storage. However, the combination
treatments of 0.5, 1% CR with CH and 1% CR with GA decreased the yellowness of wingettes
during 7 days of refrigerated storage.
4.4. Gene expression profile of C. jejuni in response to sub-inhibitory concentration of CR, CH,
and their combination.
The sub-inhibitory concentration of CR and CH was determined using growth curves (data
not shown). Figure 1 shows the effect of sub-inhibitory concentration of CR, CH, and their
combination on the expression of selected C. jejuni genes required for survival and virulence in
the host. The presence of CR at the sub-inhibitory concentration significantly up-regulated energy
taxis gene, cetB. However, CH and CR+CH combination significantly down-regulated the
expression of cetB. The expression of motility gene motA and fibronectin binding protein gene
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cadF was significantly downregulated by CR+CH combination treatment but not by CR and CH
treatments alone. The gene jlpA that helps in bacterial attachment was also reduced in expression
by CR+CH combination and CH treatment. The expression of motility gene (motB), invasion
antigen protein gene (ciaB), flagella biosynthesis RNA polymerase sigma protein gene (fliA) and
regulatory protein gene (racS) were not affected by any of the treatment groups when compared
to the control. The acetic acid treatment did not affect the expression of tested genes (P > 0.05).
5. Discussion
In this study, we evaluated the potential of GA or CH-based edible coatings fortified with
CR to reduce C. jejuni on chicken wingettes. The wingettes were used as a model to represent the
treatment of a whole carcass. The increased contact time between coating and the product
facilitates in reducing pathogen survival and also prevents subsequent contamination during
transport and post-coating handling. Both GA and CH have been extensively studied as coatings
on food products such as fresh strawberries, longan fruit, tomato, skinless frankfurters, and shell
eggs to improve food safety (El Ghaouth et al., 1991; Jiang and Li, 2001; Ali et al., 2010;
Upadhyay et al., 2015; Upadhyaya et al., 2016). GA dissolves in water at neutral pH while CH
needs an acidified solution. Therefore, aqueous solution of acetic acid at 50 mM concentration was
used to dissolve the CH powder. The gum arabic coating significantly reduced C. jejuni counts
when compared to non-coated wingettes (baseline). However, GA efficacy was similar to BPD
wash treatment suggesting that reductions observed in GA treatment were probably due to removal
of loosely attached C. jejuni cells (Table 2). Similar results were previously reported where 10%
GA coating did not inhibit mycelia growth of Colletotrichum musae and Colletotrichum.
gloeosporioides in artificially inoculated bananas and papayas (Maqbool et al., 2011). Likewise,
Jiang and colleagues (2013) observed that Pseudomonas spp., yeasts and molds counts were not
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significantly reduced by the 10% GA coating on mushrooms. Upadhyaya et al. (2016) also
observed that the presence of GA coating did not exert any antimicrobial effect on Salmonella
present on eggs as compared to controls. In contrast to GA, coatings with the 2% CH showed
significant antimicrobial activity against C. jejuni on wingettes (Table 3). Olaimat and colleagues
(2014) observed that 2% CH and 0.2% κ-carrageenan combination coating containing mustard
extract significantly reduced (up to 2.78 log10 cfu/g) C. jejuni counts on chicken breast. In the
present study, coating materials fortified with select concentrations of CR significantly improved
the antimicrobial activity of coating agents. Moreover, the antimicrobial efficacy was maintained
through 7 days of refrigerated storage. Similar results have been observed in previous studies
where the addition of CR to GA (Upadhyaya et al., 2016) or to CH (Upadhyay et al., 2015)
significantly improved the antimicrobial efficacy of coating material against S. Enteritidis on shell
eggs and L. monocytogenes on frankfurters, respectively. The presence of CR wash treatments also
reduced C. jejuni counts on wingettes and the efficacy of several CR wash treatments was similar
to the coating treatments with GA or CH. However, since wash treatments do not exert any
antimicrobial effect after initial treatment, protection from subsequent contamination event during
handling or storage is a potential concern.
The presence of aerobic bacteria such as Pseudomonas spp., in refrigerated chicken
products can reduce shelf–life and decrease food safety (Huis in't Veld, 1996; De Ledesma et al.,
1996; Kim and Marshall, 2000). In this study, we observed that direct application of CR or CR+CH
coatings inhibited the growth of total aerobic counts when compared with either non-coated or
wingettes washed with BPD control. Previously, Siripatrawan and Noipha (2012) observed that
2% CH reduced the count of total aerobic bacteria, yeast, molds and lactic acid bacteria from day
12 through 20 on pork sausages stored at 4°C. Aşik and Candoğan, (2014) found that 3% CH alone
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or in combination with different concentrations (0.5, 1 and 1.5%) of garlic oil significantly reduced
the total aerobic counts on shrimp and improved the shelf-life of products by at least 2 days. In
agreement with these studies, a recent study conducted by Jasour and co-workers (2015) reported
that CH-based coatings supplemented with lactoperoxidase extended the shelf-life of trout fillets
by at least 4 days. Chicken skin harbors different microflora, including psychotropic bacteria that
contributes to spoilage (Cox et al., 1998; Mead, 2004). We observed an increase in the total aerobic
counts throughout the sampling days in all treatments, which could be due to the growth of those
psychrophiles attached to the skin surfaces of wingettes.
Since color of the poultry product is one of the main attributes of the product which may
influence the purchasing decision for consumers, we evaluated the effect of CR and combination
treatments on the color of chicken wingettes. Among L*, a* and b* values, L* is the most
important since consumers can easily detect the changes in lightness of the products which could
affect their purchasing decisions (Guidi and Castigliego, 2010). We observed that there were no
significant differences in color values (L*, a*, b*) of chicken wingettes between treatments and
controls within the sampling day (Tables 6a, b, c). Jeong et al. (2011) observed that normal color
values (L*, a*, b*) of chicken wings cooled by different chilling methods (water, air or evaporative
air) ranged from 67 to 69 for lightness (L*), 2.7 to 4.1 for redness (a*) and 4.6 to 7 for yellowness
(b*). In this study, we observed color values for L*, a* and b* ranged from 71.19 to 73.6, 2.56 to
4.5 and 7.96 to 11.97 respectively. The slight increase in L* and b* values could be due to variation
in samples and storage procedures. Previous studies have shown that pH of the product is one of
the factors that determines the color of the product (Livingston and Brown, 1981; Yang and Chen,
1993; Allen et al., 1997). In this study, the pH of treatment solutions, including controls was ~6.5
to ~6.7. This could be one of the reasons why a change in color of wingettes within the same
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sampling day was not observed. Moreover, we observed that refrigerated storage did not affect the
lightness of samples. The redness was also not significantly affected in the majority of the
treatments when compared with day 0 versus day 7. However, a slight decrease in the yellowness
of the samples washed with the coating combinations of either GA with 1% CR or CH with 0.5
and 1% CR was observed. Ahn and Lee (2004) observed that the lightness and redness for
aerobically and vacuum packaged turkey breast meat did not significantly change during 15 days
of storage. However, they reported an increase in yellowness in aerobically-packaged samples.
The sub-inhibitory concentration of a compound refers to the maximum concentration that
does not inhibit pathogen growth. Our previous studies (Arambel et al., 2015; Upadhyay et al.,
2017; Wagle et al., 2017a, b) and other researchers (Castillo et al., 2014; Oh and Jeon, 2015;
Kovács et al., 2016) have reported that sub-inhibitory concentrations of natural compounds
including phytochemicals modulate the expression of virulent genes in major pathogens including
C. jejuni thereby potentially changing their pathophysiology and survival efficacy in the
environment. To delineate the potential mechanism of action of the tested natural compounds
against C. jejuni, we evaluated the effect of sub-inhibitory concentrations of CR (0.002%), CH
(0.0125%), and CR+CH combination on the expression of C. jejuni genes critical for survival and
virulence. Since 10% GA did not reduce C. jejuni counts on chicken wingettes when compared to
the BPD control, we did not include GA as a treatment in gene expression study. To represent the
chicken meat environment, gene expression analysis was carried out in chicken meat juice (5%
vol/vol) since chicken meat juice is known to enhance surface attachment of C. jejuni (Brown et
al., 2014), thereby, enhancing their survival in the poultry products (Birk et al., 2004).
Several recent studies have identified genes responsible for C. jejuni virulence,
colonization in the chicken gut, and infection in humans (Dasti et al., 2010; Hermans et al., 2011).
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C. jejuni genes motA, motB, fliA are essential for motility (Ketley, 1997; Young et al., 2007). The
cetA and cetB genes are responsible for energy taxis (Hendrixson et al., 2001). In addition, cadF
and jlpA are required for cell surface attachment (Jin et al., 2003; Hermans et al., 2011). In this
study, we observed that the CR treatment did not significant change the expression of a majority
of test genes except cetB. In contrast, CH down-regulated the expression of cetB and jlpA
suggesting that the two compounds could be acting by different mechanisms. The CR+CH
combination significantly downregulated the expression of motA, cadF, jlpA and cetB, indicating
that the combination treatments could modulate C. jejuni virulence and capacity to cause infections
in humans.
6. Conclusions
We observed that GA or CH-based coating with CR produced consistent reduction of C.
jejuni on chicken wingettes. The aforementioned reduction would have significant food safety
implications since a 2-log10 reduction of Campylobacter from the poultry carcass could result in
a 30-fold reduction in human infection (Rosenquist et al., 2003). In addition, the aforementioned
treatments also reduced the expression of select virulent genes of C. jejuni. Thus, CR in
combination with GA, CH coating could be used as an effective antimicrobial treatment for
controlling C. jejuni and improving safety of poultry products.
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Appendix
Tables
Table 1: Primers used for gene expression analysis using real-time quantitative PCR
Gene with Accession
no.

Primer

Sequence (5’-3’)

Gene description

16S-rRNA
(NC_002163.1)

Forward

5’-ATAAGCACCGGCTAACTCCG-3’

Reverse

5’-TTACGCCCAGTGATTCCGAG-3’

Ribosomal RNA
(housekeeping
gene)

motA (NC_002163.1)

Forward

5’-AGCGGGTATTTCAGGTGCTT-3’

(product length 75 bp)

Reverse

5’-CCCCAAGGAGCAAAAAGTGC-3’

motB (NC_002163.1)

Forward

5’-AATGCCCAGAATGTCCAGCA-3’

(product length 51 bp)

Reverse

5’-AGTCTGCATAAGGCACAGCC-3’

fliA (NC_002163.1)

Forward

5’-AGCTTTCACGCCGTTACGAT-3’

(product length 56 bp)

Reverse

5’-TCTTGCAAAACCCCAGAAGT-3’

cetB (NC_002163.1)

Forward

5’-GCCTTGTTGCTGTTCTGCTC-3’

(product length 88 bp)

Reverse

5’-TTCCGTTCGTCGTATGCCAA -3’

cadF (NC_002163.1)

Forward

5’-CGCGGGTGTAAAATTCCGTC-3’

(product length 135 bp)

Reverse

5’-TCCTTTTTGCCACCAAAACCA-3’

ciaB (NC_002163.1)

Forward

5’-TCTCAGCTCAAGTCGTTCCA-3’

(product length 50 bp)

Reverse

5’-GCCCGCCTTAGAACTTACAA-3’

jlpA (NC_002163.1)

Forward

5’-AGCACACAGGGAATCGACAG-3’

(product length 66 bp)

Reverse

5’-TAACGCTTCTGTGGCGTCTT-3

racS (NC_002163.1)

Forward

5’-AGACAAGTTGCCGAAGTTGC-3’

(product length 79 bp)

Reverse

5’-AGGCGATCTTGCCTACTTCA-3’

(product length 78 bp)
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Flagellar motor
protein
Flagellar motor
protein
Flagella
biosynthesis RNA
polymerase sigma
protein
Energy taxis
protein/motility
Outer-membrane
fibronectinbinding protein

Invasion antigen
protein
Surface exposed
lipoprotein
Two-component
sensor/histidine
kinase

Table 2: The efficacy of gum arabic (GA), carvacrol (CR) and their combinations on survival of Campylobacter jejuni on chicken
wingettes1

121

Trial Treatments
Day 0
Day 1
Day 3
Day 5
Day 7
a
a
a
a
Baseline
7.00±0.03
6.66±0.03
6.51±0.03
6.60±0.03
6.30±0.11a
BPD control
6.11±0.07b
5.53±0.07b
5.56±0.08b
5.53±0.03b
5.55±0.08b
10% GA
5.92±0.05b
5.77±0.10b
5.78±0.09b
5.71±0.02b
5.41±0.07b
c
c
cd
c
0.25% CR
4.80±0.14
4.44±0.17
4.46±0.12
4.60±0.16
4.69±0.11c
1
0.5% CR
4.00±0.18de
4.10±0.15cd
3.96±0.17e
4.03±0.14de
4.20±0.06cd
1% CR
3.62±0.31e
3.81±0.31d
2.82±0.07f
3.41±0.43f
3.59±0.10e
c
c
c
cd
0.25% CR+10% GA
4.85±0.10
4.70±0.19
4.80±0.07
4.48±0.11
4.72±0.16c
0.5% CR+10% GA
4.24±0.18d
4.30±0.36cd
4.24±0.21de
4.27±0.19cd
4.57±0.22c
1% CR + 10% GA
4.14±0.21d
3.80±0.29d
4.25±0.12de
3.48±0.27ef
3.78±0.42de
Baseline
7.00±0.09a
6.74±0.04a
6.93±0.05a
6.80±0.07a
6.84±0.09a
BPD control
6.26±0.04b
5.89±0.05b
5.80±0.04b
5.95±0.09b
5.86±0.08b
10% GA
6.45±0.09b
5.93±0.05b
6.16±0.06b
6.08±0.09b
6.06±0.06b
0.25% CR
5.39±0.14de
4.63±0.48c
5.14±0.19c
5.00±0.21cd
5.33±0.06cd
2
0.5% CR
5.61±0.17cd
4.96±0.22c
4.92±0.21cd
5.08±0.21cd
5.13±0.12cd
1% CR
5.19±0.06e
4.60±0.29c
4.68±0.37cd
4.70±0.21d
5.01±0.16d
0.25% CR+10% GA
5.80±0.14c
5.21±0.05c
5.17±0.17c
5.42±0.08c
5.38±0.14c
0.5% CR+10% GA
5.31±0.09de
5.15±0.26c
5.12±0.19c
5.33±0.18c
5.16±0.16cd
1% CR+10% GA
5.20±0.17e
5.01±0.20c
4.50±0.27d
5.24±0.15c
5.04±0.19cd
1
n = 5 replicates per treatment per day per trial. Values (log10 cfu/sample) presented as mean±standard error of the mean. Within the
same trial, within column with no common superscript differ significantly (P < 0.05).
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Table 3: The efficacy of chitosan (CH), carvacrol (CR) and their combinations on survival of Campylobacter jejuni on chicken
wingettes1
Trial Treatments
Baseline

Day 0
6.65±0.19a

Day 1
6.31±0.21a

Day 3
6.64±0.07a

Day 5
6.11±0.15a

Day 7
6.71±0.13a

BPD control

6.06±0.14a

5.89±0.14a

5.73±0.21b

5.34±0.07b

6.26±0.02ab

50 mM acetic acid

6.02±0.15a

6.11±0.10a

5.59±0.18bc

5.47±0.09b

6.03±0.13b

2% CH

4.99±0.24b

5.15±0.12b

4.69±0.23de

4.49±0.33cd

4.69±0.19de

0.25% CR

4.56±0.09bc

4.83±0.12bc

5.04±0.10cd

4.51±0.08cd

5.43±0.13c

0.5% CR

4.56±0.18bc

5.19±0.09b

4.62±0.19def

4.68±0.14c

4.95±0.36cd

1% CR

4.08±0.23c

5.16±0.11b

5.12±0.16cd

4.07±0.21d

4.94±0.07cd

0.25% CR+2% CH

5.03±0.19b

4.52±0.19c

4.07±0.23f

4.05±0.14d

4.79±0.15d

0.5% CR+2% CH

3.14±0.48c

4.37±0.09cd

4.38±0.31ef

4.13±0.18d

4.19±0.33e

1% CR+2% CH
Baseline

4.66±0.17bc
7.29±0.02a

3.90±0.40d
6.97±0.10a

4.25±0.24ef
6.64±0.20a

4.33±0.27cd
6.71±0.13a

4.54±0.20de
6.78±0.13a

BPD control

6.47±0.07b

5.64±0.13b

5.45±0.07b

5.75±0.15b

5.87±0.13b

50 mM acetic acid

6.38±0.11b

7.07±0.08a

5.96±0.17ab

5.96±0.07b

5.92±0.12b

2% CH

6.08±0.07bc

4.81±0.10d

4.28±0.09c

4.62±0.15c

4.46±0.05cde

0.25% CR

5.70±0.22cd

5.20±0.02c

3.90±0.70cd

4.71±0.16c

4.93±0.14c

0.5% CR

5.25±0.24edf

5.20±0.04c

4.23±0.19c

4.54±0.12c

4.78±0.22cd

1% CR

4.72±0.24gf

4.58±0.17de

2.96±0.54d

4.34±0.21cd

4.18±0.13e

0.25% CR+2% CH

5.31±0.29ed

4.45±0.27de

4.02±0.34c

4.48±0.29c

4.22±0.10e

0.5% CR+2% CH

4.80±0.16egf

3.99±0.13f

3.86±0.33cd

3.93±0.15d

4.33±0.28ed

1
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2

4.38±0.32g
4.39±0.11e
4.44±0.19c
3.85±0.24d
4.23±0.31e
1% CR+2% CH
1
n = 5 replicates per treatment per day per trial. Values (log10 cfu/sample) presented as mean±standard error of the mean. Within the
same trial, within column with no common superscript differ significantly (P < 0.05).
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Table 4: The efficacy of gum arabic (GA), carvacrol (CR) and their combinations on total aerobic counts on chicken wingettes1
Trial

1

123
2

Treatments

Day 0

Day 1

Day 3

Day 5

Day 7

Baseline
BPD control
10% GA
0.25% CR
0.5% CR
1% CR
0.25% CR+10% GA
0.5% CR+10% GA
1% CR+10% GA

5.34±0.18ab
5.22±0.21ab
5.69±0.35a
5.17±0.22ab
4.66±0.22bc
4.30±0.27c
4.76±0.32bc
4.06±0.23c
4.65±0.33bc

5.71±0.31ab
6.30±0.36a
5.87±0.25ab
5.37±0.29b
4.37±0.17c
5.00±0.49bc
5.12±0.32bc
5.65±0.36ab
4.34±0.27c

7.60±0.31a
7.05±0.24ab
7.22±0.23ab
6.98±0.25ab
6.55±0.32bc
6.04±0.56cd
5.91±0.32cd
5.60±0.16d
5.91±0.27cd

7.97±0.23ab
7.20±0.13cd
7.48±0.19bc
6.55±0.27e
6.65±0.11de
7.33±0.06c
7.51±0.22bc
7.74±0.29abc
8.12±0.14a

8.67±0.10a
8.02±0.22b
7.98±0.04b
7.44±0.03c
7.56±0.18bc
7.14±0.05c
8.53±0.15a
7.98±0.04b
7.60±0.19bc

Baseline

4.24±0.04bc

5.32±0.16cd

7.38±0.09ab

7.09±0.11a

8.70±0.07a

BPD control

4.22±0.14bc

6.11±0.17b

7.74±0.06a

6.99±0.07a

8.57±0.11ab

10% GA

4.83±0.35b

7.14±0.22a

7.67±0.13a

6.84±0.15ab

8.86±0.10a

0.25% CR

3.72±0.28cd

5.57±0.22bcd

6.90±0.46b

6.30±0.11de

8.26±0.13c

0.5% CR

3.79±0.12cd

5.16±0.17d

7.32±0.10ab

6.23±0.06e

8.37±0.07bc

1% CR

3.50±0.12d

5.56±0.18cd

6.80±0.15b

5.88±0.14f

8.17±0.19c

0.25% CR+10% GA

5.54±0.39a

5.73±0.23bc

7.65±0.13a

6.68±0.08bc

8.08±0.09c

0.5% CR+10% GA

6.18±0.31a

5.30±0.14cd

7.16±0.21ab

6.54±0.09cd

8.33±0.10bc

1% CR+10% GA
5.98±0.17a
5.80±0.20bc
6.03±0.27c
6.33±0.05de
8.36±0.07bc
1
n = 5 replicates per treatment per day per trial. Values (log10 cfu/sample) presented as mean±standard error of the mean. Within the
same trial, within column with no common superscript differ significantly (P < 0.05).
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Table 5: The efficacy of chitosan (CH), carvacrol (CR) and their combinations on total aerobic counts on chicken wingettes1
Trial Treatments

1

124
2

Baseline
BPD control
50 mM acetic acid
2% CH
0.25% CR
0.5% CR
1% CR
0.25% CR+2% CH
0.5% CR+2% CH
1% CR+2% CH

Day 0
7.06±0.12a
6.96±0.15a
6.62±0.18b
6.15±0.11de
6.40±0.07bcd
6.01±0.09e
6.29±0.14bcde
6.58±0.10bc
6.27±0.11cde
6.07±0.08de

Day 1
9.68±0.05a
9.56±0.03ab
9.15±0.12bc
8.74±0.19cd
8.55±0.06d
8.34±0.03de
8.64±0.17d
7.93±0.20ef
7.69±0.14f
7.04±0.38g

Day 3
8.16±0.05a
8.18±0.07a
8.00±0.11a
7.55±0.19ab
8.00±0.07a
8.11±0.20a
7.91±0.49ab
7.5±0.44ab
7.02±0.05b
7.59±0.33ab

Day 5
9.18±0.02a
9.21±0.13a
9.09±0.08a
8.32±0.06cd
8.92±0.16ab
8.85±0.17ab
8.6±0.10bc
8.56±0.09bc
7.96±0.21d
8.08±0.19d

Day 7
9.08±0.15ab
9.27±0.67a
9.28±0.16a
8.59±0.25cd
8.83±0.08bc
8.20±0.05e
8.31±0.06de
8.32±0.31de
8.57±0.04cd
8.19±0.16e

Baseline

4.5±0.15a

5.73±0.23a

6.79±0.24a

7.32±0.08ab

7.42±0.04ab

BPD control

4.06±0.23ab

5.72±0.20a

6.02±0.16ab

7.45±0.17a

7.44±0.10a

50 mM acetic acid

3.78±0.15bc

5.16±0.22b

5.77±0.18b

7.0±0.27bc

7.04±0.09cd

2% CH

3.41±0.14c

3.84±0.21de

4.92±0.26cd

6.56±0.16c

6.68±0.23d

0.25% CR

4.36±0.14a

4.70±0.23bc

5.43±0.10bc

6.89±0.11bc

7.50±0.05a

0.5% CR

3.79±0.17bc

4.35±0.23cd

5.91±0.13b

6.80±0.08c

7.45±0.11a

1% CR

3.5±0.18bc

3.75±0.16e

4.31±0.61de

6.79±0.15c

7.43±0.13ab

0.25% CR+2% CH

3.6±0.26bc

4.18±0.08cde

4.31±0.32de

6.79±0.07c

7.22±0.12abc

0.5% CR+2% CH

3.64±0.17bc

4.13±0.05de

4.24±0.07de

6.73±0.18c

7.33±0.06abc

3.31±0.30c
4.06±0.14de
4.05±0.22e
6.58±0.16c
7.07±0.20bc
1% CR+2% CH
1
n = 5 replicates per treatment per day per trial. Values (log10 cfu/sample) presented as mean±standard error of the mean. Within the
same trial, within column with no common superscript differ significantly (P < 0.05).
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Table 6a: The effect of gum arabic (GA), chitosan (CH), carvacrol (CR) and their combinations
on lightness chicken wingettes1
Lightness (L*)
Treatments

Day 0

Day 3

Day 7

Baseline

72.20±0.31

72.76±0.45

71.68±0.38

BPD control

73.16±0.33

73.60±0.22

72.96±0.22

10% GA

71.64±0.59

71.89±0.72

72.17±1.26

50 mM acetic acid

72.68±0.44

72.18±0.68

71.25±0.83

2% CH

72.91±0.43

73.05±0.74

72.48±1.22

0.25% CR

72.61±0.55

73.43±0.57

72.25±0.81

0.5% CR

73.10±0.30

72.65±0.55

72.07±0.61

1% CR

72.93±0.28

73.36±0.32

72.62±0.32

0.25% CR + 10% GA

71.73±1.35

71.89±0.60

71.53±0.44

0.5% CR + 10% GA

72.24±0.52

72.05±0.60

71.46±0.43

1% CR + 10% GA

71.53±0.74

72.03±0.45

71.19±0.59

0.25% CR + 2% CH

73.11±0.92

73.22±1.00

72.70±1.02

0.5% CR + 2% CH

72.50±0.71

73.03±0.71

72.30±0.56

1% CR + 2% CH

73.24±0.88

73.43±0.49

72.55±0.74

1

n = 5 replicates per treatment per day. Values (mean±standard error of the mean). No significant
different within the same column or within the same row (P > 0.05).
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Table 6b: The effect of gum arabic (GA), chitosan (CH), carvacrol (CR) and their combinations
on redness of chicken wingettes1
Redness (a*)
Treatments

Day 0

Day 3

Day 7

Baseline

2.98±0.42b

3.71±0.14ab

3.80±0.23a

BPD control

2.98±0.44a

2.56±0.27a

2.99±0.35a

10% GA

4.04±0.42a

3.68±0.40a

4.03±0.40a

50 mM acetic acid

3.81±0.44a

3.31±0.29a

3.86±0.34a

2% CH

3.57±0.26a

3.14±0.31a

3.63±0.66a

0.25% CR

3.48±0.74a

2.67±0.37a

3.90±0.22a

0.5% CR

3.33±0.66a

3.35±0.75a

4.27±0.28a

1% CR

3.79±0.16a

3.01±0.14b

3.71±0.24a

0.25% CR + 10% GA

4.43±0.68a

2.93±0.29b

3.90±0.60ab

0.5% CR + 10% GA

4.38±0.30a

3.54±0.35a

3.85±0.37a

1% CR + 10% GA

4.50±0.82a

2.90±0.66a

3.76±0.77a

0.25% CR + 2% CH

4.44±0.78a

3.13±0.64a

3.31±0.43a

0.5% CR + 2% CH

4.42±0.66a

3.24±0.64a

3.78±0.51a

1% CR + 2% CH

3.79±0.22a

3.18±0.29a

4.02±0.54a

1

n = 5 replicates per treatment per day. Values (mean±standard error of the mean). No significant
different within the same column (P > 0.05). Means with no common letter differ significantly (P
< 0.05) within the same row.
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Table 6c: The effect of gum arabic (GA), chitosan (CH), carvacrol (CR) and their combinations
on yellowness of chicken wingettes1
Yellowness (b*)
Treatments

Day 0

Day 3

Day 7

Baseline

10.19±0.63a

9.30±0.42a

9.05±0.83a

BPD control

9.62±0.57a

8.10±0.24a

8.30±0.51a

10% GA

9.54±0.33a

7.96±0.50a

8.8±0.60a

50 mM acetic acid

9.65±0.49a

8.61±0.33a

8.33±0.74a

2% CH

10.32±0.73a

8.66±0.96a

8.82±0.94a

0.25% CR

10.01±1.70a

8.10±1.50a

9.18±1.04a

0.5% CR

10.40±1.25a

9.60±0.96a

9.51±1.09a

1% CR

11.27±0.82a

9.3±1.00a

9.08±1.11a

0.25% CR + 10% GA

11.97±1.36a

9.73±0.59a

9.59±1.37a

0.5% CR + 10% GA

10.78±0.79a

8.03±0.94a

8.41±1.27a

1% CR + 10% GA

10.98±0.37a

8.66±1.09b

8.97±0.68b

0.25% CR + 2% CH

10.72±0.69a

8.6±1.00a

9.23±0.71a

0.5% CR + 2% CH

11.82±0.74a

9.62±0.56b

9.98±0.32b

1% CR + 2% CH

11.55±0.66a

8.56±0.71b

9.06±0.55b

1

n = 5 replicates per treatment per day. Values (mean±standard error of the mean). No significant
different within the same column (P > 0.05). Means with no common letter differ significantly (P
< 0.05) within the same row.
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Figure

Figure 1. The effect of 0.002% carvacrol (CR), 0.0125% chitosan (CH) and 0.002% CR +
0.0125% CH on the expression of selected virulent genes of C. jejuni S-8. 16S-rRNA served as
endogenous control. Results are averages of two independent experiments, each containing
duplicate samples (mean and SEM). *Indicates significantly down or up-regulated genes (P <
0.05).
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Conclusions
Campylobacter jejuni is one of the leading causes of bacterial gastroenteritis worldwide
and its infection in humans is strongly associated with the consumption and/or mishandling of raw
contaminated poultry products. Thus, interventions aiming to reduce C. jejuni counts on poultry
products could greatly reduce the incidence of human campylobacteriosis. With increasing
consumer demand for natural and minimally processed foods, the use of generally recognized as
safe (GRAS) status antimicrobials is gaining attention for improving safety of poultry products.
In this project we evaluated the antimicrobial efficacy of a GRAS compound, carvacrol
(CR; derived from oregano oil), as an antimicrobial wash treatment to reduce C. jejuni on chicken
skin (Study 1). Three delivery systems of CR: suspension, emulsion and nanoemulsion were used.
Skin samples were inoculated with a cocktail of four wild strains of C. jejuni (~8 log10 cfu/sample),
and were randomly divided to CR (0.25, 0.5, 1 or 2%) suspension, emulsion or nanoemulsion.
Samples were washed in the respective treatment solutions for 1 min, followed by drip drying for
2 min, and sampled at 0, 8 or 24 h post-storage at 4°C. C. jejuni counts were reduced up to 4 log10
cfu/sample by 2% dose of CR suspension at 0 h (P < 0.05). Carvacrol emulsion or nanoemulsion
did not show any additional reduction in C. jejuni counts when compared to suspension.
In the second study, the efficacy of gum arabic (GA) or chitosan (CH) coatings fortified
with CR to reduce C. jejuni on chicken wingettes was investigated as an additional intervention to
increase the antimicrobial activity of CR. Inoculated chicken wingettes (~7.5 log10 cfu of C.
jejuni/sample) were randomly assigned to baseline, control (0%), CR (0.25, 0.5 or 1%), GA (10%),
CH (2%) or their combinations. After 1 min of coating, wingettes were air dried (1 h) and sampled
at days 0, 1, 3, 5, and 7. Results showed that all three doses of CR, CH or GA-based coating
fortified with CR reduced C. jejuni from day 0 through 7 by up to 3.0 log10 cfu/sample (P < 0.05).
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Moreover, the antimicrobial efficacy of GA was improved by CR and the coatings reduced C.
jejuni by ~1 to 2 log10 cfu/sample at day 7. In addition, CH-CR coatings reduced total aerobic
counts on majority of storage time when compared with non-coated samples. No significant
difference in the color of chicken wingettes was observed between treatments. Exposure of this
pathogen to sublethal concentrations of CR, CH or combination significantly modulated select
genes encoding for energy taxis (cetB), motility (motA), binding (cadF) and attachment (jlpA).
In conclusion, carvacrol as an antimicrobial wash on chicken skin and the coating
treatments on chicken wingettes was effective in reducing C. jejuni. Since a 2-log10 reduction of
C. jejuni from poultry carcass translates into more than 30-fold reduction in the risk of human
Campylobacter infections, the aforementioned treatments represent a safe, effective and natural
approach that could improve poultry product safety.
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